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ABSTRACT

The sensitive, selective, and practical detection of aliphatic alcohols is a continuing
technical challenge with significant impact in public health work and environmental
remediation efforts. Reported in the first manuscript is the use of a β-cyclodextrin
derivative to promote proximity-induced interactions between aliphatic alcohol analytes
and a brightly colored organic dye, which result in highly analyte-specific color changes
that enabled accurate alcohol identification. Linear discriminant analysis of the color
changes enabled resulting in 100% differentiation of the colorimetric signals obtained from
methanol, ethanol, and isopropanol in combination with BODIPY and Rhodamine dyes.
The resulting solution-state detection system has significant broad-based applicability
because it uses only easily available materials to achieve such detection, with moderate
limits of detection obtained. Future research with this sensor system will focus on
decreasing limits of detection as well as on optimizing the system for quantitative detection
applications.
Reported in Chapter 2 of this thesis are our efforts towards the development of similar
cyclodextrin-based systems for the detection of anabolic steroids that are of interest in
illegal doping scandals. These systems, in close analogy to other systems developed in our
group, rely on the fact that combining the target analytes with a high quantum yield
fluorophore results in a measurable, analyte-specific change in the fluorophore emission
signal. Promising results were seen in our solution-state detection of anabolic steroids via
the use of β-cyclodextrin derivatives as supramolecular scaffolds and Rhodamine 6G as
the signal transducing element. Using linear discriminant analysis, arrays were generated,
illustrating the differentiation and classification of the analytes with high selectivity in the
system. Limits of detection falling below the micromolar range show a high sensitivity of

the system. Current efforts are focused on improving the reproducibility of these
experiments to enable a high functioning detection system as well as efforts toward moving
to a solid-state detection system.
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PREFACE
This thesis is presented in manuscript format according to the guidelines of the graduate
school of the University of Rhode Island. Two manuscripts will be presented in this thesis.
Chapter 1 is published in ACS Omega with authors Anna Haynes, Priva Halpert, and Mindy
Levine. Chapter 2 is being submitted for publication to RSC Advances with authors Anna
Haynes and Mindy Levine.
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ABSTRACT
The sensitive, selective, and practical detection of aliphatic alcohols is a continuing
technical challenge with significant impact in public health work and environmental
remediation efforts. Reported herein is the use of a β-cyclodextrin derivative to promote
proximity-induced interactions between aliphatic alcohol analytes and a brightly colored
organic dye, which result in highly analyte-specific color changes that enabled accurate
alcohol identification. Linear discriminant analysis of the color changes enabled resulting
in 100% differentiation of the colorimetric signals obtained from methanol, ethanol, and
isopropanol in combination with BODIPY and Rhodamine dyes. The resulting solutionstate detection system has significant broad-based applicability because it uses only easily
available materials to achieve such detection, with moderate limits of detection obtained.
Future research with this sensor system will focus on decreasing limits of detection as well
as on optimizing the system for quantitative detection applications.
INTRODUCTION
Increased interest in using non-mass spectrometry-based techniques for the detection of
small organic compounds has arisen due to practical challenges associated with the use of
mass spectrometry that limit broad-based applicability.1–3 Such challenges include the fact
that expensive, bulky instrumentation is often required in order to accomplish mass
spectrometry-based detection combined with significant user training to operate the
instrumentation, which prevents detection by relatively untrained citizen scientists.4 Many
newly developed chemosensors have focused on systems that allow for portable, on-site
testing of the target analytes, without requiring high-end, costly laboratory
instrumentation.5,6 A challenging aspect of designing portable chemosensors is the need to
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maintain high selectivity, sensitivity, and broad-based applicability in the efficient
detection of various analytes, especially among analytes that might be similar in structure
and size.
By utilizing the ability of cyclodextrin to act as a supramolecular scaffold that facilitates
proximity-induced, highly analyte-specific interactions between an analyte of interest and
a high quantum yield fluorophore, the Levine group has developed sensitive and selective
fluorescence-based systems for toxicant detection.7–10 The systems utilize cyclodextrinpromoted fluorescence energy transfer from a toxicant to a high quantum yield fluorophore,
for photophysically-active analytes,11 or cyclodextrin-promoted, toxicant-specific
fluorescence modulation, for non-photophysically active analytes.8 In addition to
monitoring the analyte-specific fluorescence changes, there are often analyte-specific color
changes in the fluorophore, promoted through the cyclodextrin-assisted interaction of the
brightly colored fluorophore and the target analyte.12 Advantages of colorimetric detection
include the fact that the color changes can be easily detected using naked eye detection13
or RGB analysis.14 Significant literature precedent indicates that colorimetric analysis can
be optimized for detection of very small concentrations of toxicants, both in solution-state
as well as in solid-state detection devices.15–17
Colorimetric detection has potential utility in the detection of aliphatic alcohols, a class of
analytes commonly found in commercial products that, in high concentrations, can cause
health concerns.18–20 These alcohols, including isopropanol, ethanol, and methanol, are
found in household cleaners,21 paints,22 self-care and beauty products,23 as well as in
beverages.24 Moreover, the need for detection of aliphatic alcohols is rising with the
increasing prevalence of at-home beer and alcohol production.25 With almost no regulation
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of this process currently in place, there is significant potential for poorly regulated ethanol
concentrations26 as well as the potential for methanol contamination and associated
methanol toxicity.27 Furthermore, the brewing process can sometimes lead to the formation
of other byproducts including n-propanol, isobutanol, and isoamyl alcohol.28 Because
methods to detect these byproducts are not widely available, significant public health risks
from their ingestion remain.29 Additional potential applications of colorimetric aliphatic
alcohol detection include the use of a colorimetric device to detect alcohol intoxication in
both medical30 and law-enforcement settings.31,32 Finally, forensic post-mortem analysis
would benefit from the detection of a range of aliphatic alcohols that are byproducts of
certain bacteria and could provide important information as in a forensic investigation. 31,33
While the fluorescence modulation method used previously in the Levine group provided
good sensitivity and high selectivity among structurally similar analytes, it required
laboratory-grade instrumentation, which severely limits widespread usage. Although
portable fluorimetry has been accomplished using smartphone-based systems,15,34–38 these
systems can be challenging for the user to implement, which means that portable
colorimetric systems can have notable advantages. Reported herein is the development of
an extremely practical colorimetric detection system for isopropanol, ethanol, and
methanol, based on color changes in a dye-cyclodextrin complex upon addition of the
aliphatic alcohol, with such color changes intimately dependent on the structure of each of
the alcohols and its association with both the cyclodextrin scaffold and the colorimetric
dye. This system is highly robust, with alcohol-induced color changes detectable even by
a high school student) working with unpurified tap water solutions, and even in its
optimized formulation uses no laboratory-grade instrumentation. Rather, the system uses a
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spray-painted plastic box equipped with LED lights to facilitate consistent coloration and
enable reproducible results.
EXPERIMENTAL SECTION

Figure 1: Structure of alcohol analytes (1-3) and highly colored dyes (4-5)
Materials and Methods: The alcohol analytes 1-3 and dyes 4 and 5 shown in Figure 1 were
obtained from Millipore-Sigma chemical company and the cyclodextrins were obtained
from Tokyo Chemical Industry (TCI) chemical company. All chemicals were used as
received. All aqueous solutions were made in glass jars and transferred to 50 mL white,
polypropylene cups that had previously been used in a Keurig machine and were washed
thoroughly prior to usage. A plastic container (with dimensions 21 cm x 15 cm x 7 cm)
was painted using Krylon Fusion Satin Black spray paint to limit ambient light, and a 1.5
cm x 1.5 cm hole was cut in the center of the lid to enable photography of the solution. An
additional polypropylene cup previously used for a Keurig machine was positioned under
the opening and secured to the bottom of the container with electrical tape. Two strips of
LED white light tape (purchased from The Home Depot) were placed on the interior of the
container, on all sides of the container, to provide uniform sample illumination. An
annotated figure of the lightbox can be found in the Electronic Supporting Information.
5

The cup that contained sample was placed into the secured cup prior to imaging. Photos of
the solutions were taken from 2.0 cm above the top of the sample cup with a Samsung
Galaxy S8+ (model number: G950U) on manual mode with the following settings: ISO set
to 100, aperture set to 1/350, macro focused (close-up focus), and the white balance set at
5500K. These settings were kept constant for all trials to avoid variation in color capture.
Images were processed with ImageJ software to measure the red, green and blue values
(RGB) of the solutions, following the procedures detailed below.
General procedure for making stock solutions: Three 250 mL solutions of β-cyclodextrin
(β-CD), methyl-β-cyclodextrin (Me-β-CD), and 2-hydroxypropyl-β-cyclodextrin (2-HP-βCD) cyclodextrin were made at relatively high concentrations (Table 1). The stock
solutions for dyes 4 and 5 were made in isopropanol at concentrations of 3.80 mM and 2.08
mM respectively (1 mg/mL for each dye). Diluted dye solutions were prepared by adding
5.0 mL of the concentrated stock solutions to a 150 mL volumetric flask and diluting to the
mark with water.
Table 1: Concentration of cyclodextrins and dyes in solution.a
Solute
β-CD
Me-β-CD
2-HP-β-CD
Dye 4
Dye 5

Solvent
DI H2O
DI H2O
DI H2O
Isopropanol
Isopropanol

Concentration (mM)
16.5
9.69
2.39
3.82
2.08

a

The final solution concentrations were calculated based on the amounts of solute and solvent
added. See text for more information.

General procedure for the optimization of supramolecular cyclodextrin host: In a glass
sample jar, 10.00 mL of β-CD stock solution was combined with 10.00 mL of one of the
diluted dye solutions. This mixture was manually shaken for one minute to ensure thorough

6

mixing. After mixing, 5.00 mL of alcohol was added. This mixture was transferred to the
sample cup and placed in the lightbox. The cover was placed on and a photo was taken
using the smartphone with the settings listed above. This procedure was repeated for Meβ-CD and 2-HP-β-CD with both dyes and each of the three alcohols (18 total samples).
Four trials of each sample were completed with a calculated average standard deviation in
red, green and blue values of 0.08%, 0.14%, and 1.99% respectively.
General procedure for the optimization of analyte concentration: Preparation of the
cyclodextrin-dye solution was performed following the procedures detailed above, with 2HP-β-CD used as the host. A 0.5 M solution of the alcohol was made by adding alcohol to
the cyclodextrin-dye solution in the glass jar, with additional samples tested for each
alcohol at a variety of concentrations (0.5 M, 1.0 M, 2.0 M, and 3.0 M) using both dye 4
and 5 (8 samples, 3 trials each). These solutions were transferred to a sample cup, placed
in the lightbox, and a photo was taken of every sample.
General procedure for calculating the limits of detection (LOD) and limits of quantification
(LOQ): The limit of detection (LOD), defined as the lowest concentration of the analyte
that can be detected, was obtained using the calibration curve method, following
procedures reported by Loock and co-workers.39 The limit of detection of the blank
(LODblank) is defined according to Equation 1, below:
LODblank = mblank + 3(SDblank)

Eq. 1

where m is the average of the values obtained from the blank sample and SD is the standard
deviation of those measurements. The limit of quantification (LOQ), the lowest
concentration of analyte that can be quantified.40 The limit of quantification of the blank is
defined according to Equation 2, below:
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LOQblank = mblank + 10(SDblank)

Eq. 2

where m is the average of the values obtained from the blank sample and SD is the standard
deviation of those measurements.
The cyclodextrin-dye solution was prepared as mentioned above using only 2-HP-β-CD as
a supramolecular host. This solution was transferred to the sample cup and placed in the
spray-painted box. A photograph was taken in order to obtain the blank measurement of
the solution, in the absence of any alcohol. Using a 20-200 μL Fisherbrand Elite
micropipette, 100 μL of an alcohol was added and a picture was taken. These 100 μL
additions continued until 6.0 mL of alcohol had been added to the solution. This process
was repeated three times for each alcohol and in the presence of each dye. The RGB values
of the solution were used to determine the level of detection of each alcohol in both dyes.
General procedure for obtaining RGB values: Photos were cropped to be the same
500x500 pixel ratio focused on the center of the sample (using https://www.birme.net) to
ensure the area of the picture that was being measured was consistent across all samples.
These images were processed using the RBG measurement tool plug-in that is available
for the ImageJ software. Figures of these procedures can be found in the Electronic
Supporting Information of this manuscript.
General procedure for conducting linear discriminant analyses: SYSTAT 13 statistical
computing software was used to quantify the degree of separation of color change in the
solutions using the following settings for linear discriminant analysis (LDA): (a) Classical
Discriminant Analysis; (b) Grouping Variable: Analytes (alcohols); (c) Predictors: Red,
Green, Blue; (d) Long-Range Statistics: Mahal.7
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General procedure for computational modeling: Spartan ’18 was used to calculate the
equilibrium values for the analytes in their ground-state electric potential surfaces using a
semi-empirical PM3 model for each analyte. Molecular Operating Environment 2018
(MOE) was used to do the docking studies for each dye, alcohol analyte, and 2-HP-β-CD
host. A general energy minimization was performed using the “quick prep” function on the
software. For the docking studies, the set of atoms defined as the receptor was both 2-HPβ-CD and the solvent so that the dye could move freely in the system. Placement was done
using the Triangle Matches method with London Dispersion dG score in 30 poses.
Refinement was done using the Rigid Receptor method with GBVI/WSA dG score in 5
poses. This generated the docking of the dye-cyclodextrin complex with the lowest energy
confirmation. Summary figures generated from these procedures can be found in the
Supporting information of this manuscript.
RESULTS AND DISCUSSION
Optimization of cyclodextrin
A variety of cyclodextrin hosts were screened, with the goal of determining which
supramolecular host would provide maximum separation between the analyte-induced
color changes, with such separation quantified as the “cumulative proportion of total
dispersion.” An example of significant dispersion of analyte clusters is shown for 2-HP-βCD (Figure 2C), and a contrasting example with overlapping areas between clusters is
shown for Me-β-CD (Figure 2B). Using linear discriminant analysis of the RGB data
collected from the sample photos, it was determined that the 2-HP-β-CD had the highest
dispersion using both dye 4 and 5 as color-changing elements, with cumulative proportion
of total dispersion values of 1.000 and 0.998 respectively (Table 2). Similar trends in the
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cyclodextrin host were seen with dye 5 (Figure 3), with 2-HP- β-CD showing the greatest
dispersion (Figure 3C) compared to of β-CD and Me-β-CD (Figure 3A and 3B,
respectively).

Figure 2. Generated arrays for the detections of ethanol, isopropanol, and methanol with
each cyclodextrin supramolecular host using dye 4: (A) β-cyclodextrin; (B) Methyl-βcyclodextrin; and (C) 2-hydroxypropyl-β-cyclodextrin

Figure 3. Generated arrays for the detections of ethanol, isopropanol, and methanol with
each cyclodextrin supramolecular host using dye 5: (A) β-cyclodextrin; (B) Methyl-βcyclodextrin; and (C) 2-hydroxypropyl-β-cyclodextrin
Table 2: Cumulative proportions of total dispersion for each
cyclodextrin with dye 4 and 5.a
Dye

β-CD

Me-β-CD

2-HP-β-CD

4

0.915

0.986

1.000

5

0.778

0.749

0.998

a

Values were generated after analysis using SYSTAT 13
LDA software.
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The higher signal dispersion that was observed when using 2-HP-β-CD is likely due to
strong binding between the dyes and 2-HP-β-CD, as well as the high flexibility and water
solubility of 2-HP-β-CD compared to the other hosts investigated.41 High binding constants
between the alcohol analytes and cyclodextrin hosts increase the strength of interactions
between the analyte, host and dye, resulting in more sensitive analyte-induced signal
changes, whereas greater flexibility and water solubility increase the availability of this
host to participate in the desired interactions. 42–44
Further insight into the selectivity observed between the alcohol analytes was obtained
from computational investigations. Electrostatic potential mapping of analytes 1-3,
generated using Spartan ’18 software, showed significant similarities in the analyte
structures, with areas of high polarity around the hydroxyl group (Figure 4). Differences
between the analytes include noticeable size differences as well as a more concentrated
region of positive electron density in analyte 1 compared to the other analytes, as shown
by the dark blue color. Such differences contribute to differing binding affinities with the
cyclodextrin, resulting in turn in high specificity in the analyte-induced color changes.

Figure 4. Electrostatic potential maps of (A) analyte 1; (B) analyte 2; and (C) analyte 3.
Red areas indicate regions of negative electron density and blue areas indicate regions of
positive electron density. These computations were done using Spartan ‘18 software.
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Determining the optimal concentrations for testing
In order to determine the optimal analyte concentration to achieve high degrees of analyteinduced separation in the colorimetric responses, the dependence of the LDA plots on
analyte concentration was explicitly investigated, and the results are summarized in Table
3. These results indicate that dye 4 was more effective in characterizing data at high analyte
concentrations (3.0 M, Figure 5), whereas dye 5 provided more dispersed and accurate
results between 0.5 M and 2.0 M concentrations (Figure 6). A plausible explanation for
these observed results relates to the higher binding constant between dye 4 and 2-HP-βCD of 3.32x105 M-1 compared to 1.59 x 105 M-1 between dye 5 and the cyclodextrin. The
lower binding constant of dye 5 allows for better detection at lower alcohol concentrations
because the dye is being displaced easier. Because dye 4 binds with a slightly higher
binding energy, a higher concentration of alcohol needs to be added to the system in order
to displace the dye, causing an overall decrease in system performance.
Table 3: Percent correct classification values obtained from
Jackknifed Classification analysis of the arrays.a
Dye

0.5 M

1.0 M

2.0 M

3.0 M

4

56

22

67

89

5

67

100

100

78

a

Values taken after linear discriminant analysis was
conducted using SYSTAT version 13 software.
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Figure 5. Linear discriminant analysis results obtained at 3.0 M analyte concentration for:
(A) dye 4 and (B) dye 5. All results were obtained using SYSTAT version 13 and following
the procedures detailed in the experimental section.

Figure 6. Linear discriminant analysis results generated at lower analyte concentrations.
(A) Dye 4 at 0.5 M concentration analyte; (B) Dye 4 at 1.0 M concentration analyte; (C)
Dye 4 at 2.0 M concentration analyte; (D) Dye 5 at 0.5 M concentration analyte; (E) Dye
5 at 1.0 M concentration analyte; and (F) Dye 5 at 2.0 M concentration analyte. All results
were obtained using Systat version 13 and following the procedures detailed in the
experimental section.
Additional computational studies conducted using MOE 2018 software provided important
information about the lowest energy docking conformation of each dye with 2-HP-β-CD,
13

and results are shown in Figure 7. Of note, BODIPY (4) exhibited markedly more inclusion
in the cyclodextrin host compared to Rhodamine (5), with a substantial portion of the dye
remaining exposed to the solvent. This solvent-exposed area of Rhodamine has a greater
ability to interact with the analyte in solution, resulting in more responsiveness at lower
analyte concentrations compared to BODIPY.
This result implies that dye displacement by the alcohol may not be necessary to affect a
color change if the alcohol and dye interact via the solvent-accessible portion. Such
interactions are not dependent on the binding constant of the dyes in cyclodextrin and
provide an additional mechanism by which the system can lead to analyte-specific color
changes. Efforts to investigate the extent to which either or both mechanisms (i.e., dye
displacement from the cavity and/or interactions between the dye and analyte through
solvent exposed areas) are operative in this system are currently underway in our
laboratory.
Moreover, the addition of the alcohol analyte to the solution of dye in cyclodextrin had
measurable changes on the supramolecular complex. In particular, computational results
indicated that adding methanol to a solution of BODIPY in 2-HP-β-CD resulted in the
weakening of the association between BODIPY and 2-HP-β-CD and strengthening of the
affinity of the BODIPY for the solvent (Figure 8). This result supports that colorimetric
changes induced by the addition of the alcohol analyte are a result of decreased affinity of
the dye for the hydrophobic cyclodextrin cavity.
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Figure 7: Lowest energy conformations of BODIPY (4) and Rhodamine (5) in 2-HP-βCD. (A) Side view of the complex with BODIPY (4). (B) Aerial view of the complex with
BODIPY (4). (C) Side view of the complex with Rhodamine (5). (D) Aerial view of the
complex with Rhodamine (5). Color coding: for the cyclodextrin host, the dark blue color
represents the carbon atoms, the red color represents the oxygen atoms, and the gray color
represents hydrogen atoms. For BODIPY, the purple color represents carbon atoms, gray
represents hydrogen, blue represents nitrogen, orange represents boron, and green
represents fluorine. For Rhodamine, the teal color represents carbon, gray represents
hydrogen, red represents oxygen, and dark blue represents nitrogen.
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Figure 8: Lowest energy conformations of BODIPY (4) in 2-HP-β-CD following the
introduction of methanol. The methanol is modeled as teal stick figures, and the colors of
the BODIPY and cyclodextrin are identical to the colors used in Figure 7.
Determining the LOD and LOQ for the analytes with dyes 4 and 5
In addition to measuring the ability of the system to differentiate between structurally
similar analytes, the sensitivity of the system to low analyte concentrations was also
investigated. These results are summarized in Table 4 (for 0.127mM BODIPY and
0.093mM Rhodamine) and Table 5 (for 0.382mM BODIPY and 0.280mM Rhodamine),
and indicate that analyte concentrations as low as 0.2 M were detectable via this method
(for isopropanol using relatively high concentrations of Rhodamine). Compared to the
LODs reported in Table 3, there was no significant decrease in the LODs observed with
BODIPY. In contrast, the Rhodamine trial showed much better improvement at higher dye
concentrations with a 48% decrease in the LOD and a decrease of 68% in the LOQ value.
These marked changes are in line with the higher solvent and analyte accessibility
16

displayed by Rhodamine (vide supra), and indicate substantial promise in the further
optimization of sensitive alcohol sensors. An example of a color array that illustrates the
visible color change of BODIPY in the presence of isopropanol is shown in Figure 9.
Table 5: LODs and LOQs of each alcohol with dyes 4 and 5 in the
presence of 2-HP-β-CD.
Dye
4

5

Alcohol

LOD (M)a

LOQ (M)b

Isopropanol
Ethanol
Methanol
Isopropanol
Ethanol
Methanol

0.319
0.491
0.249
0.386
0.216
0.331

0.805
1.74
0.823
1.05
0.442
0.730

a

Values calculated according to Equation 1 and the equation of the line of best fit for each dyealcohol complex.
b
Values calculated according to Equation 2 and the equation of the line of best fit for each dyealcohol complex.

Table 6: LODs and LOQs of isopropanol with increased concentrations of
dye 4 and 5 and 2-HP-β-CD.
Dye
4
5
a

LOD (M)
0.3170 (0.50%) a
0.2004 (48%)

LOQ (M)
0.7812 (3.0%)
0.3341(68%)

Number in parentheses represents the percent change, in all cases a
decrease, from the LOD values obtained in Table 4 to the ones calculated
using a higher concentration of dye in solution.

Figure 9. Colorimetric array of the 60 samples from the trial using dye 4 and analyte 3.
The concentration of analyte increases from left to right.
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CONCLUSIONS
Harnessing the highly specific complexation of small molecules guests inside
supramolecular cyclodextrin hosts provides a fundamentally unique system for the
detection of those guests. Reported herein is the application of such host-guest complexes
for the colorimetric detection of alcohol, using highly practical, easily available materials
to achieve excellent selectivity (100% differentiation) and moderate sensitivity (as low as
0.2 M). Computational experiments involving the cyclodextrin, analytes, and highly
colored dyes are invoked to explain the underlying basis of this strong analyte specificity,
as remarkably structurally similar analytes leading to noticeably different colorimetric
read-out signals. Efforts to improve the sensitivity and broaden the scope of such detection
are currently underway in our laboratory, and results of these and other investigations will
be reported in due course.
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MATERIALS AND METHODS
The alcohol analytes and dyes were obtained from Millipore Sigma chemical company and
the cyclodextrins were obtained from Tokyo Chemical Industry chemical company, and all
chemicals were used as received. Samples were illuminated using the homemade lightbox
detailed on the following page. All photos were taken with a Samsung Galaxy S8+ (model
number: G950U) on manual mode with the following settings: ISO set to 100, aperture set
to 1/350, macro focused (close-up focus), and the white balance set at 5500K. Images were
cropped using software from https://www.birme.net. Fluorescence measurements for the
binding experiments were performed using a Shimadzu RF 6000 spectrophotometer. Both
the excitation and emission slit widths were set to 3.0 nm. All fluorescence spectra were
integrated vs. wavenumber on the X-axis using OriginPro 2019 Version 9.60. All arrays
were generated using SYSTAT Version 13.1.
DETAILS OF ANALYTES AND DYES

Figure 10: Structure of alcohol analytes and highly colored dyes
All analytes were used as received. The dyes were prepared at a concentration of 1.0
mg/mL in isopropanol. Diluted dye solutions were prepared by diluting 5.0 mL of the
concentrated stock solutions with 150 mL of DI H2O, based on the dilution factor used by
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high school student Priva Halpert. The final concentrations of the dyes are shown in the
table below.
Table 7. Concentration of Dyes in Solution

4

Concentration before
Dilution (mM)
3.796

Final Concentration
(mM)
0.1265

5

2.079

0.0693

Dye Number

EXPERIMENTAL DETAILS FOR CYCLODEXTRIN SOLUTIONS
The method for making the cyclodextrin solutions was taken from the previous work of
high school student Priva Halpert working under the supervision of Dr. Levine. As a high
school student working remotely, Halpert based her measurements on volume of each
component, using teaspoons, cups, etc. In her procedure, 0.5 teaspoon of cyclodextrin
was added to 0.25 cups (59.15 mL). We wanted to replicate her procedure and converted
her measurement of 0.5 teaspoons to grams for each cyclodextrin and scaled up to make a
solution with a final volume of 250 mL. These conversions are summarized in the table
below, together with the final concentrations of the cyclodextrins.
Table 8. Volume to Mass Conversions of Cyclodextrins and Final Concentrations

Cyclodextrin

Mass of 0.5
teaspoons (g)

Mass added to 250
mL of DI H2O (g)

Final
Concentration
(mM)

β-Cyclodextrin

1.470

4.6806

16.49

Methyl-βCyclodextrin

0.750

3.1717

9.685

2-hydroxypropylβ-CD

0.778

3.2852

2.389
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EXPERIMENTAL DETAILS FOR CONSTRUCTION OF THE LIGHTBOX
A plastic container (with dimensions 21 cm x 15 cm x 7 cm) was painted using Krylon
Fusion Satin Black spray paint to limit ambient light, and a 1.5 cm x 1.5 cm hole was cut
in the center of the lid to enable photography of the solution. An additional polypropylene
cup previously used for a Keurig machine was positioned under the opening after
thoroughly washing, and secured to the bottom of the container with electrical tape. Two
strips of LED white light tape (purchased from The Home Depot) were placed on the
interior of the container, on all sides, and turned on to provide uniform sample illumination.

Figure 11. Annotated dimensions of lightbox

Figure 12. Annotated top-view of lightbox

Figure 13. Illuminated lightbox

Figure 14. Illuminated lightbox
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EXPERIMENTAL DETAILS FOR CROPPING PHOTOGRAPHS AND RGB
MEASUREMENTS
All photographs were cropped using the online tool found at https://www.birme.net.
Photos from the same trial were uploaded to the site then cropped to a 500x500 pixel
ratio (Figure 15). The cropped photos were then opened into the ImageJ software. These
measurements were recorded using the RGB measurement plug-in provided in the
software (Figure 16).

Figure 15. Cropping sample photos to 500x500 pixel ratio using software on
https://www.birme.net
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Figure 16. Processing of cropped sample photo using the ImageJ software RGB
Measurement plug-in.

EXPERIMENTAL

DETAILS

FOR

THE

OPTIMIZATION

OF

THE

SUPRAMOLECULAR CYCLODEXTRIN HOST
In a glass sample jar, 10.0 mL of β-cyclodextrin stock solution was combined with 10.0
mL of one of the diluted dye solutions. This mixture was manually shaken for 1 minute to
ensure a homogeneous mixture. After mixing, 5.0 mL of alcohol was added. This mixture
was transferred to the sample cup and placed in the lightbox. The cover was placed on
and a photo was taken using the smartphone with the settings detailed above. This
procedure was repeated for methyl-β-cyclodextrin and 2-hydroxypropyl-β-cyclodextrin
with both dyes and each of the three alcohols (18 total samples). These samples were
replicated 4 times in total with an average standard deviation in RGB values of 0.70%.
Full summary tables of standard deviation and standard deviation percentages can be seen
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on page S15. As a control, experiments were also conducted in the absence of
cyclodextrin but under otherwise identical conditions. Summary tables and figures from
these experiments are included herein.
EXPERIMENTAL DETAILS FOR THE OPTIMIZATION OF ANALYTE
CONCENTRATION
In a glass sample jar, 10.0 mL of 2-hydroxypropyl-β-cyclodextrin stock solution was
combined with 10.0 mL of one of the diluted dye solutions. This mixture was manually
shaken for 1 minute to ensure a homogeneous mixture. A 0.5 M solution of the alcohol was
made by adding the corresponding amount of alcohol to the cyclodextrin-dye solution in
the glass jar, with additional samples tested for each alcohol at a variety of concentrations
(0.5 M, 1.0 M, 2.0 M, and 3.0 M) using both BODIPY and Rhodamine dyes (8 samples
replicated 3 times each). The volume of alcohol necessary to obtain an 0.5 M solution is
seen in the table below. These solutions were transferred to a sample cup, placed in the
lightbox, and a photo was taken of each.
Table 9. Amount of Alcohol Added in Each Solution
Cyclodextrin

0.5 M

1.0 M

2.0 M

3.0 M

Isopropanol

0.790 mL

1.650 mL

3.590 mL

5.915 mL

Ethanol

0.600 mL

1.240 mL

2.640 mL

4.240 mL

Methanol

0.415 mL

0.845 mL

1.765 mL

2.770 mL

EXPERIMENTAL DETAILS FOR LIMIT OF DETECTION EXPERIMENTS
The limit of detection (LOD), defined as the lowest concentration of the analyte that can
be detected, was obtained using the calibration curve method, following procedures
reported by Loock et. al. The limit of quantification (LOQ) is the lowest concentration of
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analyte that can be quantified. The limit of detection1 and quantification2 experiments were
conducted following literature-reported procedures.
To determine the LOD and LOQ, each dye-analyte combination in 2-hydroxypropyl-βcyclodextrin solution was examined in the following manner:
1. In a glass sample jar, 10.0 mL of 2-hydroxypropyl-β-cyclodextrin stock solution was
combined with 10.0 mL of one of the diluted dye solutions. This mixture was manually
shaken for 1 minute to ensure a homogeneous mixture.
2. The solution was transferred to a sample cup and subsequently placed in the light box.
A photo was taken in order to obtain the blank measurement of the solution (i.e. in the
absence of any alcohol, before any analyte had been added).
3. Using a 20-200 μL Fisherbrand Elite micropipette, 100 μL of an alcohol was added and
a picture was taken. These 100 μL additions continued until 6.0 mL of alcohol was in
solution.
4. Steps 1-3 were repeated 3 times for each dye-analyte combination (6 combinations, 18
total samples).
5. Photos were cropped to a 500x500 pixel ratio centered on the center of the sample cup
using software from https://www.birme.net and the RGB values of the photos were
measured using the RGB measurement plug-in tool in the ImageJ software.
6. The Green values (Y-axis) were chosen to be plotted verses the molarity (X-axis),
because they exhibited the most consistent trends. Calibration curves were generated, fitted
with an exponential function and an equation was determined.
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7. The limit of the blank is defined according to the following equation:
𝐿𝑂𝐷𝐵𝑙𝑎𝑛𝑘 = 𝑚𝐵𝑙𝑎𝑛𝑘 + 3(𝑆𝐷𝐵𝑙𝑎𝑛𝑘 ),

Equation 1.

where m is the average of the values obtained from the blank sample and SD is the standard
deviation of those measurements.
8. The limit of the blank was entered as the y-value in the equation from step 6, and the
corresponding x-value was calculated. This value was the LOD of the system in M.
9. The LOQ was determined in a similar procedure to the LOD. The limit of quantification
blank is defined according to the following equation:
𝐿𝑂𝑄𝐵𝑙𝑎𝑛𝑘 = 𝑚𝐵𝑙𝑎𝑛𝑘 + 10(𝑆𝐷𝐵𝑙𝑎𝑛𝑘 ).

Equation 2.

This value is then inputted as the y-value in the equation from step 6, and the corresponding
x-value was calculated. This value is the LOQ for the system in M.
EXPERIMENTAL DETAILS FOR BINDING CONSTANT EXPERIMENTS
Fluorescence measurements were performed on a Shimadzu RF 6000 spectrophotometer.
Both the excitation and emission slit widths were set to 3.0 nm.
A 1.45 mM solution of 2-HP-β-CD was prepared in DI H2O. A solution of 2.09 mM Dye
5 was prepared in DI H2O and a 2.54 mM solution of Dye 4 was prepared in
tetrahydrofuran, with the solvent selection and concentration optimized based on
concentration. In both binding experiments, 2.50 mL of water was added to quartz cuvette.
In the Dye 5 trial, 8 μL of the dye was added. In the Dye 4 series, 10.5 μL was added. The
tip of the micropipette was used to stir the solution in the cuvette to ensure a homogeneous
mixture. Fluorescence measurements of these were taken 4 times. In each trial, 1 μL of the
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2-HP-β-CD solution was added to the cuvette and the same scanning process was
completed. This was repeated for the total addition amounts seen on page S19 in Tables
S10 and S11, the total addition amount representing the concentration at which the
observed signal plateaued. All fluorescence spectra were integrated vs. wavenumber on the
X-axis using OriginPro 2019 Version 9.60. Binding constants (Ka) were determined using
the equation shown below:
𝐹/𝐹0 = 1 + ((𝐹/𝐹0 )𝑚𝑎𝑥 − 1)(𝐾𝑎 [𝐺]0 /(1 + 𝐾𝑎 [𝐺]0 ),

Equation 3.

where F is the fluorescence of the sample, F0 is the fluorescence of the blank, [G] is the
concentration of the guest which in this case is 2-HP-β-CD, and Ka is the binding constant.
The average Ka was determined to be 3.32 x 105 M-1 and 1.59 x 105 M-1 for Dye 4 and 5
respectively.
EXPERIMENTAL DETAILS FOR ARRAY GENERATION EXPERIMENTS
Array analysis was performed using SYSTAT 13 statistical computing software with the
following settings:
(a) Classical Discriminant Analysis
(b) Grouping Variable: Analytes
(c) Predictors: Red, Green, Blue
(d) Long-Range Statistics: Mahal
Arrays were generated for all analyte-dye-cyclodextrin combinations in the optimization
experiments.
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EXPERIMENTAL DETAILS FOR COMPUTTIONAL MODELING
Spartan ’18 was used to calculate the equilibrium at ground state in gas using a semiempirical PM3 model for each analyte (Figure 8). This allowed an electrostatic potential
map surface to be overlaid on the molecules. Molecular Operating Environment 2018
(MOE) was used to do the docking studies for each dye and 2-HP-β-CD. A general energy
minimization was performed using the “quick prep” function and the default settings. For
the docking studies, the set of atoms defined as the receptor was both 2-HP-β-CD and the
solvent so that the dye could move freely in the system. Placement was done using the
Triangle Matches method with London Dispersion dG score in 30 poses. Refinement was
done using the Rigid Receptor method with GBVI/WSA dG score in 5 poses (Figure 9).
This generated the docking of the dye-cyclodextrin complex with the lowest energy
confirmation.

Figure 17. Spartan dialogue box with the settings used for calculation of equilibrium
geometry.
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Figure 18. MOE 2018 dialogue box with the settings used for the docking calculations.

SUMMARY TABLES FOR OPTIMIZATION OF CYCLODEXTRIN
EXPERIEMNTS
Table 10. RGB Measures of Cyclodextrin-Analyte Combinations with Dyes 4 and 5
Dye 4
Cyclodextrin

Analyte

Isopropanol

β-CD

Ethanol

Methanol

M-β-CD

Isopropanol

Red
229.326
229.686
229.522
229.631
228.556
228.86
228.839
228.928
228.012
228.335
228.145
228.218
229.38
229.672
229.307
229.49

Green
162.309
162.166
162.683
161.993
164.062
163.756
164.402
163.684
162.721
162.413
162.91
162.214
159.869
159.58
159.911
159.772
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Dye 5
Blue
2.674
2.711
2.708
2.696
3.058
3.086
2.95
2.902
2.156
2.136
2.119
2.182
2.965
2.986
2.972
2.983

Red
248.446
248.196
248.35
248.282
245.065
244.803
244.971
244.848
246.063
245.885
246.043
245.953
248.249
248.513
248.176
248.353

Green
125.19
125.264
125.206
125.225
125.688
125.694
125.699
125.665
126.866
126.996
126.965
126.986
125.159
124.875
125.165
124.985

Blue
1.782
1.796
1.791
1.792
1.8
1.851
1.808
1.834
1.569
1.788
1.625
1.729
3.753
3.746
3.736
3.717

Ethanol

Methanol

Isopropanol

2-HP-β-CD

Ethanol

Methanol

229.054
229.35
229.012
229.109
229.02
229.946
228.449
229.372
236.315
236.88
236.55
236.641
233.448
233.62
233.931
234.134
238.767
238.893
238.56
238.496

159.4
159.669
158.958
159.563
159.398
159.065
159.348
159.128
185.085
185.564
185.294
185.368
158.496
158.678
158.977
159.18
155.928
156.037
155.729
155.653

2.789
2.846
2.826
2.771
2.81
2.559
2.787
3.001
4.147
4.111
4.103
4.129
3.736
3.735
3.676
3.704
3.401
3.379
3.384
3.365

247.118
247.392
247.011
247.155
248.061
248.378
247.963
248.14
258.453
257.953
258.259
258.174
259.583
259.392
259.093
258.895
257.994
257.877
258.159
258.098

124.484
123.999
124.875
124.981
124.455
124.153
124.484
124.334
165.344
164.814
165.094
165.003
167.58
167.38
167.151
167.015
160.909
160.841
161.11
161.219

4.095
4.05
4.086
4.09
3.459
3.405
3.614
3.573
2.221
2.176
2.182
2.184
2.677
2.599
2.604
2.654
2.843
2.961
2.372
3.22

Table 11. Standard Deviations of RGB Measures of All Cyclodextrin-Analyte
Combinations with Dyes 4 and 5
Cyclodextrin
β-CD

Me-β-CD

2-HP-β-CD

Analyte
Isopropanol
Ethanol
Methanol
Isopropanol
Ethanol
Methanol
Isopropanol
Ethanol
Methanol

Red
0.1589
0.1643
0.1353
0.1588
0.1511
0.6278
0.2336
0.3076
0.1837

Dye 4
Green
0.2935
0.3279
0.3107
0.1473
0.3132
0.1630
0.1979
0.3048
0.1768
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Blue
0.0168
0.0873
0.0271
0.0097
0.0341
0.1810
0.0196
0.0287
0.0149

Red
0.1058
0.1190
0.0826
0.1462
0.1607
0.1771
0.2072
0.3063
0.1238

Dye 5
Green
0.0319
0.0150
0.0596
0.1413
0.4452
0.1504
0.2202
0.2496
0.1752

Blue
0.0059
0.0235
0.0990
0.0156
0.0205
0.0973
0.0205
0.0382
0.2407

Table 12. Percent Standard Deviations of RGB Measures of Cyclodextrin-Analyte
Combinations with Dyes 4 and 5
Cyclodextrin
β-CD

Me-β-CD

2-HP-β-CD

Analyte
Isopropanol
Ethanol
Methanol
Isopropanol
Ethanol
Methanol
Isopropanol
Ethanol
Methanol

Red
0.069%
0.072%
0.059%
0.069%
0.066%
0.274%
0.099%
0.132%
0.077%

Dye 4
Green
0.181%
0.200%
0.191%
0.092%
0.196%
0.102%
0.107%
0.192%
0.113%

Blue
0.623%
2.911%
1.262%
0.327%
1.216%
6.489%
0.476%
0.772%
0.439%

Red
0.043%
0.049%
0.034%
0.059%
0.065%
0.071%
0.080%
0.118%
0.048%

Dye 5
Green
0.025%
0.012%
0.047%
0.113%
0.357%
0.121%
0.133%
0.149%
0.109%

Blue
0.330%
1.290%
5.900%
0.418%
0.502%
2.769%
0.934%
1.450%
7.766%

SUMMARY TABLES FOR CONCETRATION OPTIMIZATION EXPERIEMNTS
Table 13. RGB Measures of Varying Concentrations of Analyte in 2-HP-β-CD Solution
with Dyes 4 and 5
Analyte

Concentration
0.5 (M)

1.0 (M)
Isopropanol
2.0 (M)

3.0 (M)

0.5 (M)

Ethanol

1.0 (M)

2.0 (M)

Red
238.111
238.416
238.381
238.845
239.22
239.194
238.872
240.322
239.51
235.774
237.338
236.972
238.143
237.959
238.281
238.783
238.571
239.398
239.414
238.579

Dye 4
Green
147.305
146.03
145.778
150.321
148.409
148.797
164.365
159.668
156.642
184.183
187.3
181.636
146.809
146.661
148.452
148.084
147.951
150.663
152.039
150.438
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Blue
2.193
2.177
2.097
2.277
2.258
2.261
2.656
2.625
2.554
3.744
3.54
3.29
2.198
2.206
2.257
2.215
2.262
2.331
2.434
2.327

Red
254.733
254.733
254.706
254.754
254.769
254.773
254.667
254.666
254.683
254.65
254.662
254.65
254.725
254.735
254.682
254.752
254.762
254.738
254.718
254.7

Dye 5
Green
156.79
156.705
156.172
159.842
159.741
158.386
164.322
164.221
163.836
164.844
164.798
164.483
156.132
156.577
154.636
157.888
158.104
157.438
161.873
162.154

Blue
1.866
1.839
1.781
2.522
2.529
2.243
2.479
2.542
2.64
2.401
2.418
2.443
1.76
1.885
1.694
2.139
2.21
2.098
2.658
2.702

3.0 (M)

0.5 (M)

1.0 (M)
Methanol
2.0 (M)

3.0 (M)

239.706
239.551
238.263
239.108
238.6
240.228
240.219
238.891
240.041
240.045
239.694
240.747
240.915
239.049
240.847
241.502

153.549
157.139
157.975
159.737
148.121
149.071
148.381
149.142
148.84
148.386
152.425
151.426
150.847
154.9
154.191
153.745

2.493
2.594
2.623
2.593
2.255
2.255
2.263
2.281
2.236
2.246
2.403
2.355
2.356
2.53
2.51
2.5

254.714
254.656
254.667
254.693
254.625
254.662
254.666
254.727
254.7
254.704
254.751
254.753
254.758
254.711
254.726
254.708

162.028
164.283
164.842
164.471
154.415
154.439
154.457
156.382
155.996
155.403
159.123
158.592
158.342
161.973
161.574
162.272

2.555
2.502
2.409
2.493
1.642
1.688
1.713
1.829
1.801
1.85
2.361
2.332
2.218
2.679
2.642
2.586

Table 14. Standard Deviations of RGB Measures of Varying Concentrations of Analyte
in 2-HP-β-CD Solution with Dyes 4 and 5
Dye 4
Analyte
Isopropano
l

Ethanol

Methanol

Concentratio
n
0.5 (M)
1.0 (M)
2.0 (M)
3.0 (M)
0.5 (M)
1.0 (M)
2.0 (M)
3.0 (M)
0.5 (M)
1.0 (M)
2.0 (M)
3.0 (M)

Dye 5

Red

Green

Blue

Red

Green

Blue

0.1669
0.2094
0.7267
0.8181
0.1615
0.4296
0.5849
0.6544
0.9373
0.6651
0.6618
1.2701

0.8186
1.0107
3.8915
2.8368
0.9941
1.5288
1.5557
1.3262
0.4910
0.3805
0.7983
0.5825

0.0514
0.0102
0.0523
0.2274
0.0320
0.0583
0.0841
0.0170
0.0046
0.0236
0.0274
0.0153

0.0156
0.0100
0.0095
0.0069
0.0282
0.0121
0.0095
0.0190
0.0226
0.0146
0.0036
0.0096

0.3350
0.8130
0.2565
0.1965
1.0168
0.3398
0.1407
0.2844
0.0211
0.4931
0.3988
0.3502

0.0434
0.0047
0.0811
0.0211
0.0970
0.0567
0.0754
0.0513
0.0360
0.0246
0.0756
0.0468
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Table 15. Percent Standard Deviations of RGB Measures of Varying Concentrations of
Analyte in 2-HP-β-CD with Dyes 4 and 5
Analyte

Concentration
0.5 (M)
1.0 (M)
Isopropanol
2.0 (M)
3.0 (M)
0.5 (M)
1.0 (M)
Ethanol
2.0 (M)
3.0 (M)
0.5 (M)
1.0 (M)
Methanol
2.0 (M)
3.0 (M)

Red
0.070%
0.088%
0.303%
0.346%
0.068%
0.180%
0.244%
0.274%
0.391%
0.278%
0.275%
0.528%

Dye 4
Green
0.559%
0.678%
2.429%
1.539%
0.675%
1.027%
1.023%
0.838%
0.331%
0.256%
0.527%
0.378%

Blue
2.386%
0.451%
2.002%
6.451%
1.441%
2.571%
3.480%
0.655%
0.205%
1.048%
1.157%
0.608%

Red
0.006%
0.004%
0.004%
0.003%
0.011%
0.005%
0.004%
0.007%
0.009%
0.006%
0.001%
0.004%

Dye 5
Green
0.214%
0.510%
0.156%
0.119%
0.653%
0.215%
0.087%
0.173%
0.014%
0.316%
0.251%
0.216%

Blue
2.375%
0.187%
3.177%
0.873%
5.451%
2.637%
2.860%
2.078%
2.142%
1.346%
3.281%
1.776%

SUMMARY TABLES OF LOD AND LOQ EXPERIMENTS
Table 16. Table of LODs and LOQs of Each Alcohol with Dyes 4 and 5 in the Presence
of 2-HP-β-CD
Dye
Dye 4

Dye 5

Analyte
Isopropano
l
Ethanol
Methanol
Isopropano
l
Ethanol
Methanol

LOD (M)

LOQ (M)

Equation

R2

0.3187

0.8053

y = 3.304ex/1.163 + 141.606

0.9994

0.4911
0.2492

1.7387
0.8235

y = 1.531ex/1.351 + 145.250
y = 8.048ex/4.913 + 139.175

0.9973
0.9986

0.3856

1.0539

y = -14.641ex/-1.665 + 167.917

0.9799

0.2163
0.331

0.4416
0.7304

y = -21.511ex/-4.405 + 175.206
y = -26.284ex/-7.820 + 179.275

0.9935
0.9964

SUMMARY TABLES FOR BINDING EXPERIMENTS
Total addition amounts of 2-HP-β-CD added into the cuvette with the dye solution.
Additions were stopped when the fluorescence measurements begin to plateau. Full
experimental details can be seen on page S11.
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Table 17. Additions and Concentrations
for Binding of Dye 4 in 2-HP-β-CD
Volume
of 2HP-βCD
added
(μL)
0
1
2
3
4
5
6
7
8
12
16
20
24
28

[2-HP-βCD] (μM)

[Dye 4]
(μM)

0.0000
0.5790
1.158
1.736
2.313
2.890
3.467
4.043
4.619
6.918
9.209
11.49
13.77
16.04

6.383
6.380
6.378
6.375
6.373
6.370
6.368
6.365
6.362
6.352
6.342
6.332
6.322
6.312

Table 18. Additions and Concentrations
for Binding of Dye 5 in 2-HP-β-CD
Volume
of 2HP-βCD
added
(μL)
0
1
2
3
4
5
6
7
8
12
16
20
24
28
32
36
40

[2-HP-βCD] (μM)

[Dye 5]
(μM)

0.0000
0.5790
1.158
1.736
2.313
2.890
3.467
4.043
4.619
6.918
9.209
11.49
13.77
16.04
18.32
20.58
22.83

6.659
6.656
6.654
6.651
6.648
6.646
6.643
6.640
6.638
6.627
6.617
6.606
6.596
6.585
6.575
6.565
6.554

SUMMARY TABLES OF COLORIMETRIC ARRAY EXPERIMENTS
Summary Tables of Cyclodextrin-Analyte Combinations with Dyes 4 and 5 Arrays
Table 19. Analytes with β-CD and Dye 4

Table 20. Analytes with Me-β-CD and Dye 4
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Table 21. Analytes with 2-HP-β-CD and Dye 4 Table 23. Analytes with Me-β-CD and Dye 5

Table 22. Analytes with β-CD and Dye 5

Table 24. Analytes with 2-HP-β-CD and Dye 5

Summary Tables for RGB Measures of Varying Concentrations of Analyte in 2Hydroxypropyl-β-Cyclodextrin Solution with Dyes 4 and 5 Arrays
Table 25. 0.5 M Analyte solution in 2HP-β-CD with Dye 4

Table 27. 2.0 M Analyte solution in 2HP-β-CD with Dye 4

Table 26. 1.0 M Analyte solution in 2HP-β-CD with Dye 4

Table 28. 3.0 M Analyte solution in 2HP-β-CD with Dye 4
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Table 29. 0.5 M Analyte solution in 2HP-β-CD with Dye 5

Table 31. 2.0 M Analyte solution in 2HP-β-CD with Dye 5

Table 30. 1.0 M Analyte solution in 2HP-β-CD with Dye 5

Table 32. 3.0 M Analyte solution in 2HP-β-CD with Dye 5

SUMMARY TABLES FOR CONTROL EXPERIMENTS
Table 33. Analytes with Dye 4 in the absence of cyclodextrin

Table 34. Analytes with Dye 5 in the absence of cyclodextrin
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SUMMARY FIGURES COLORIMETRIC ARRAY EXPERIMENTS

Figure 19. Analytes with β-CD and Dye 4

Figure 22. Analytes with β-CD and Dye 5

Figure 20. Analytes with Me-β-CD and Dye 4

Figure 23. Analytes with Me-β-CD and Dye 5

Figure 21. Analytes with 2-HP-β-CD and Dye 4

Figure 24. Analytes with 2-HP-β-CD and Dye 5
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Figure 25. 0.5 M Analytes in 2-HP-β-CD with Dye 4

Figure 29. 0.5 M Analytes in 2-HP-β-CD with Dye 5

Figure 26. 1.0 M Analytes in 2-HP-β-CD with Dye 4

Figure 30. 1.0 M Analytes in 2-HP-β-CD with Dye 5

Figure 27. 2.0 M Analytes in 2-HP-β-CD with Dye 4

Figure 31. 2.0 M Analytes in 2-HP-β-CD with Dye 5

Figure 28. 3.0 M Analytes in 2-HP-β-CD with Dye 4

Figure 32. 3.0 M Analytes in 2-HP-β-CD with Dye 5
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SUMMARY FIGURES FOR CONTROL EXPERIMENTS

Figure 33. Analytes with Dye 4 in the absence of cyclodextrin

Figure 34. Analytes with Dye 5 in the absence of cyclodextrin
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SUMMARY FIGURES FOR ALL LOD EXPERIMENTS
Red lines on each graph are representative of the lines of best fit of the equations given
on page S18 in Table S9.

Figure 35. Analyte 1 – Dye 4

Figure 36. Analyte 2 – Dye 4
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Figure 37. Analyte 3 – Dye 4

Figure 38. Analyte 1 – Dye 5
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Figure 39. Analyte 2 – Dye 5

Figure 40. Analyte 3 – Dye 5
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ABSTRACT
The detection of anabolic steroids, particularly those that are commonly used in illegal
doping scandals, remains a high priority research objective with applications in public
health, law enforcement, and a variety of sporting disciplines. Reported herein are our
efforts to address this objective, through the use of cyclodextrin-promoted interactions
between the analyte of interest and a high quantum yield fluorophore, which lead to
measurable, analyte-specific changes in the fluorophore emission signal. By using a variety
of β-cyclodextrin derivatives (unmodified β-cyclodextrin, methyl-β-cyclodextrin, and 2hydroxypropyl-β-cyclodextrin) in combination with high quantum yield Rhodamine 6G as
a fluorophore, we were able to detect a variety of anabolic steroid analytes with 100%
differentiation between structurally similar analytes and micromolar level limits of
detection. Overall, these results show significant potential in the development of practical,
fluorescence-based steroid detection devices.
INTRODUCTION
The detection of steroids using sensitive, selective, and portable methods is of significant
interest in a variety of contexts, particularly in athletic and sporting scenarios in which
illegal anabolic steroid use has been reported.1 Such illegal use has been increasing in
recent years at all levels, including in youth athletic programs, and the lack of effective
methods for steroid detection means that the usage is likely to increase unless a rapid,
sensitive, selective, and easy-to-use method is developed.2 Detection methods that
currently exist suffer from a variety of drawbacks,3 including the need for expensive
laboratory instrumentation and significant sample preparation prior to analysis, that make
them impractical for on-site usage at sporting events.4 As such, a new method is needed.
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One approach to a fundamentally new detection method has been developed by the Levine
group in recent years, and relies on the use of cyclodextrin as a supramolecular scaffold to
promote proximity-induced interactions between the analyte of interest and a high quantum
yield fluorophore that leads to effective fluorescence detection.5 Such detection has been
demonstrated for a variety of analytes, including polycyclic aromatic hydrocarbons,6
bisphenols,7 pesticides,8,9 and alcohols,10 and in a variety of contexts, including in the
complex matrices of human breast milk,11 urine,7 and saliva.12 High detection sensitivity
and selectivity has also been demonstrated, and is maintained even in the aforementioned
complex biological matrices. The fact that the read-out signal of such sensors is a rapid and
measurable change in the fluorescence emission signal means that such a system is easily
translatable for on-site measurements. The use of such a fluorescence-based detection
system for steroid detection has not been reported to date, despite the advantages of the
system and the known challenges with effective steroid detection.
Reported herein is the cyclodextrin-promoted fluorescence detection of five anabolic
steroids: mesterolone, oxandrolone, oxymesterolone, trenbolone, and stanozolol
(compounds 1-5, Figure 1). When these analytes are combined with cyclodextrin hosts and
Rhodamine 6G (compound 6), highly sensitive, analyte-specific changes in the
fluorescence emission of the fluorophore results. Particularly promising results were seen
using β-cyclodextrin (β-CD) and its derivatives, methyl-β-cyclodextrin (Me-β-CD) and 2hydroxypropyl-β-cyclodextrin (2-HP-β-CD), as the supramolecular hosts with Rhodamine
6G as the fluorophore signaling element, with limits of detection as low as 0.05 μM
obtained and 100% success in separating the signals obtained from the five steroid analytes
using linear discriminant analysis. Overall, these results provide a promising proof-of-
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concept for successful steroid detection using cyclodextrin-promoted fluorescence changes
and indicate that such a system can eventually be used for on-site detection of illegal doping
in competitive sporting scenarios.
EXPERIMENTAL SECTION
Materials and Methods. The anabolic steroid analytes, buffer chemicals, Rhodamine 6G,
tetrahydrofuran (THF), and dimethyl sulfoxide (DMSO)-d6 were obtained from SigmaAldrich Chemical company and the cyclodextrins were obtained from Tokyo Chemical
Industry. All chemicals were used as received without further purification. All fluorescence
measurements were performed using a Shimadzu RF 6000 spectrophotometer. The
excitation and emission slit widths were set to 3.0 nm. All fluorescence spectra were
integrated vs. wavenumber on the X-axis using OriginPro 2019 Version 9.60. All arrays
were generated using SYSTAT Version 13.1. NMR studies were conducted using a Bruker
400 MHz NMR and spectra were analyzed using MestReNova 14.1 software. Electrostatic
potential map models were generated using Spartan ’18 software.
Fluorescence Modulation Experiments In six 15 mL glass vials, 100.0 µL of fluorophore
6 solution (0.1 mg/mL) in THF, 2.00 mL of a 10 mM cyclodextrin solution in citrate buffer
and 0.400 mL 0.1 M citrate buffer were combined. These solutions were left to stabilize
for 48 hours in a dark drawer and then transferred into a quartz cuvette. To the first cuvette,
5.00 µL of analyte 1 was added, in the second cuvette, 5.00 µL of analyte 2 was added, and
so on until analyte 5 was added to a cuvette. 5.00 µL of THF was added to the last cuvette
as a control. The solutions were excited at 490 nm and the fluorescence spectra were
recorded from 500-800 nm. This was repeated for each cyclodextrin solution as well as in
a cyclodextrin-free control, where citrate buffer was used instead of a cyclodextrin
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solution. The entire procedure was then repeated using 10.00 µL and 20.00 µL additions
of analyte instead of 5.00 µL additions. All captured fluorescence spectra were integrated
vs. wavenumber on the X-axis. The fluorescence modulation of each analyte was
determined using Equation 1, below:
Fluorophore Ratio = Flanalyte / Flblank

(Eq. 1)

where Flanalyte represents the integrated fluorescence emission of the fluorophore in the
presence of the analyte, and Flblank represents the integrated fluorescence emission of the
fluorophore in the absence of analyte. All trials were repeated four times and the reported
modulation values represent the average of those repeated trials with the standard deviation
values from those trials included as well.
Limit of Detection Experiments The limit of detection (LOD), defined as the lowest
concentration of the analyte that can be detected, and the limit of quantification (LOQ),
defined as the lowest concentration of analyte that can be reliably quantified were also
calculated. The limit of detection and quantification experiments were obtained using the
calibration curve method, following literature-reported procedures.13,14 Limit of detection
and limit of quantification experiments were done with sequential 5 µL additions of
analyte, to the same initial solution matrix described in the fluorescence modulation
experiments (see ESI for more details).
Array Generation Experimental Details Arrays were generated using SYSTAT 13
statistical computing software with the following settings9: (a) Classical discriminant
analysis, (b) Grouping variable: Analytes, (c) Predictors: β-cyclodextrin (β-CD), methylβ-cyclodextrin (Me-β-CD), and 2-hydroxypropyl-β-cyclodextrin (2-HP-β-CD), and (d)
Long-range statistics: Mahal. These experiments were then repeated using only two
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predictors instead of all three, and the results of array-based analysis for each pair of
predictors are also reported herein.
Computational Experiments Spartan ’18 was used to calculate the equilibrium values of
the analytes in their ground-state electric potential surfaces using a semi-empirical PM3
model for each analyte.
1

H NMR Titration Experiments All analytes and cyclodextrin solutions were prepared at a

concentration of 10 mM in deuterated DMSO (dimethyl sulfoxide-d6). Trials with a total
volume of 0.50 mL were prepared in Wilmad precision NMR tubes by combining varying
ratios of analyte to the β-CD solution (see ESI for more details). A 1H NMR spectrum was
taken of each using a Bruker 400 MHz NMR. These NMR spectra were analyzed for
shifting and broadening of peaks using MestReNova software.
RESULTS AND DISCUSSION
Selection of Analytes and Fluorophore The selected anabolic steroids were selected
because they are included in the lists of banned and misused substances in athletic
competitions,15 and because of their significant structural similarities derived from their
synthesis from testosterone.16 Fluorophore 6 was chosen due to its efficiency in
fluorescence based detection systems, which has been proven and reported both by this
group8,17 and others.18,19
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Figure 41: Structure of anabolic analytes [Mesterolone (compound 1); Oxandrolone
(compound 2); Oxymetholone (compound 3); Stanozolol (compound 4); and Trenbolone
(compound 5)] and Rhodamine 6G fluorophore (compound 6)
Selection of Cyclodextrin Hosts Cyclodextrins were chosen as the supramolecular hosts in
this study because of their known ability to interact with various guest molecules, including
steroids,20–22 due to their ability to promote non-covalent intermolecular interactions
including hydrogen bonding, hydrophobic interactions in the interior cavity, and van der
Waals interactions.23–26 β-cyclodextrin in particular has a well-documented ability to bind
a variety of hydrophobic analytes, including steroids with significant structural similarity
to analytes 1-5.10,27–30 α-Cyclodextrin and γ-cyclodextrin, by contrast, with average cavity
diameters of 5.2 Å and 8.4 Å, respectively, were determined to have non-ideal size matches
with analytes of average diameters of 5.6 Å.31 The two derivatives of β-cyclodextrin
selected, methyl-β-cyclodextrin and 2-hydroxypropyl-β-cyclodextrin, have significant
structural similarities to the unmodified analogue, but their notable differences in
hydrophobicity, solubility, and steric accessibility means that the binding of analytes 1-5
in these derivatives is expected to differ from binding in the unmodified β-cyclodextrin
host.32–37 As a result, the use of three different supramolecular hosts was expected to lead
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to selectivity in array-based linear analysis, an expectation that was successfully borne out
in experiments (vide infra).6,38
Fluorescence Modulation Experiments In order to show that each steroid is capable of
inducing a measurable change in fluorescence emission that is unique for each host-steroidfluorophore combination, fluorescence modulation experiments were performed with each
analyte-cyclodextrin combination, together with control trials run in the absence of a
cyclodextrin host. Small amounts of the steroids in THF were added to a solution of
cyclodextrin and fluorophore 6 that had been left to stabilize for 48 hours. The fluorescence
emission of the fluorophore was measured at an excitation wavelength of 490 nm and
compared to the fluorescence emission spectra of the fluorophore after the addition of 5
µL, 10 µL, and 20 µL of the analytes. The degree of fluorescence modulation of the curves
is the ratio of the fluorescence emission without analyte to the fluorescence emission of the
fluorophore with analyte, calculated according to Equation 1. The results of the analyteinduced fluorescence modulation obtained after adding 20 µL of steroid solution are
summarized in Table 1 and Figure 2, below.

Table 34. Fluorescence ratios obtained for the addition of analytes 1-5 with various
cyclodextrins in the presence of fluorophore 6a
Analyte

β-CD

Me-β-CD

2-HPCD

No CD

1

0.948 ± 0.001

0.932 ± 0.000

0.892 ± 0.000

0.994 ± 0.001

2

0.974 ± 0.001

0.966 ± 0.001

0.947 ± 0.000

0.987 ± 0.000

3

0.978 ± 0.001

0.954 ± 0.000

0.955 ± 0.000

1.004 ± 0.003

4

0.975 ± 0.000

0.986 ± 0.001

0.952 ± 0.000

0.972 ± 0.001

5

0.975 ± 0.001

0.969 ± 0.001

0.988 ± 0.001

1.036 ± 0.001

a

All values were obtained after the addition of 20 µL of steroid solution. The results were calculated using
Equation 1 and represent an average of at least four trials.
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Figure 42. Fluorescence modulation of fluorophore 6 in the presence of all hosts induced
by 20 µL additions of (A) analyte 1 (B) analyte 2 (C) analyte 3 (D) analyte 4 and (E) analyte
5. Curves were normalized so that the highest fluorescence intensity for each panel was set
to 1.0.
These results show that adding various steroid analytes to a cyclodextrin-fluorophore
solution leads to measurable, analyte-specific fluorescence modulation. In the trials where
cyclodextrin was present, each analyte induces a unique response, showing a key role for
the cyclodextrin in enabling fluorescence modulation. In contrast, the cyclodextrin-free
controls showed minimal fluorescence modulation, with less differences between the
analytes observed. Moreover, in the vast majority of cases, the addition of steroid analytes
caused a decrease in the observed fluorophore emission, represented by a fluorescence
modulation value less than 1. This decrease is likely due to the fact that the steroids cause
a displacement of the fluorophore from the cyclodextrin cavity, which increases the
availability of non-radiative decay pathways and in turn leads to a decrease in fluorescence.
Analyte 5 in the absence of cyclodextrin represents a notable exception to this trend, and
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may be a result of the reported fluorescence activity of analyte 5,39–42 which can interfere
with the observed fluorophore emission signal.
Another way of viewing these analyte-specific changes is through calculating the percent
differences induced by each analyte when compared to the blank (i.e. analyte-free sample)
in the same host solution. These values were calculated according to Equation 2, below:
Percent (%) difference = (1 – Flratio) x 100%

(Eq. 2)

where Flratio is the value found in Table 1. The percent differences obtained for each analyte
in each host-fluorophore solution were calculated, and the results are summarized in Table
2 and Figure 3, below.
Table 35. Percent (%) difference between the fluorescence emission without analyte and
the fluorescence emission after the addition of analytea
Analyte

β-CD

Me-β-CD

2-HP-β-CD

No CD

1
2
3
4
5

5.235
2.555
2.157
2.481
2.542

6.834
3.391
4.639
1.362
3.114

10.76
5.265
4.529
4.752
1.233

0.566
1.346
-0.444b
2.759
-3.609b

a

Percent difference determined after the addition of 20 µL of analyte, using the fluorescence modulation
ratios determined in Table 1 and entered into Equation 2
b
Negative values represent a situation where the fluorescence signal with analyte was greater than the signal
without analyte

Figure 43. The absolute value of the percent difference values from Table 2, grouped by
(A) the various cyclodextrin hosts and (B) the analytes (compounds 1-5) in solution.
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Figure 3A groups the percent difference values by hosts, allowing for better visualization
of which cyclodextrin host facilitates the most modulation of fluorescence. Among the
various hosts that were investigated, 2-HP-β-CD showed the greatest analyte-induced
fluorescence modulation overall. This result is likely due to the high aqueous solubility of
2-HP-β-CD, which provides increased interaction between the cyclodextrin and the analyte
and increased opportunities for analyte-induced fluorescence modulation. Variability
between analyte-induced responses was also seen using Me-β-CD, which is likely due to
the increased hydrophobicity of the cyclodextrin host that facilitates increased analytecyclodextrin interactions and concomitant variations in the observed modulation values. In
contrast to the two substituted β-cyclodextrin hosts, unmodified β-cyclodextrin showed the
least analyte-induced fluorescence modulation, which is likely due to a combination of
limited aqueous solubility and flexibility and a less hydrophobic internal cavity, all of
which combine to limit the intermolecular interactions between the cyclodextrin and the
analyte and the resultant analyte-induced fluorescence modulation. As stated previously,
the control trials without cyclodextrin displayed the lowest average fluorescence
modulation, highlighting the critical role of cyclodextrin in promoting highly analytespecific interactions with the high quantum yield fluorophore.
Among the various analytes investigated, analyte 1 was able to induce the highest degree
of fluorescence modulation in the cyclodextrin hosts, whereas analyte 5 induced the lowest
degree of modulation (Figure 3B). Moreover, analytes 2-4 have a similar, intermediate
level of analyte-induced modulation when introduced in a cyclodextrin system. Differences
in analyte-induced responses can be explained with the aid of computed electrostatic
potential maps, which showing the molecular charge distributions (Figure 4), and the
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quantitative electrostatic surface values (Table 3), which show minimum and maximum
electrostatic potentials, dipole moments and polarized surface area.

Figure 44. Spartan-calculated electrostatic potential maps of (A) analyte 1 (B) analyte 2
(C) analyte 3 (D) analyte 4 and (E) analyte 5. The areas in the dark blue shade corresponds
to electron-deficient, non-polar regions of the model and scales to the red regions,
corresponding to the electron-rich, polar regions of the molecule. Color code for the
molecular models: dark grey: carbon (C), light grey: hydrogen (H), red: oxygen (O), and
light purple: nitrogen (N).
Table 36. Quantitative values calculated from the electrostatic potential maps of the
steroids in Spartan 18’
Analyte

Minimum
Electrostatic
Potential (kJ/mol)a

Maximum
Electrostatic
Potential (kJ/mol)b

Dipole
Moment (D)c

Polar
Surface
Area (Å2)d

1

-262.3

114.2

2.11

34.117

2

-301.9

114.4

5.14

41.129

3

-262.4

114.1

2.69

48.988

4

-348.4

123.7

3.69

43.486

5

-257.9

100.7

2.23

34.214

a

Corresponds to the red, electron-rich regions of the electrostatic potential maps
Corresponds to the dark blue, electron-poor regions of the electrostatic potential maps
c
D: abbreviation of the unit debye, dipole moment resulting from two charges of opposite sign but an equal
magnitude of 10−10 statcoulomb
d
Polar areas that occur due to electronegative elements and hydrogen atoms attached to them in a molecule
b
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Overall, the main differences in the analyte structures occurs in the polar, electron-rich
region on the left side of the molecule, the region where the minimum electrostatic potential
fluctuates. This potential is used to gauge how reactive different regions of the molecule
will be in the presence of varying species of molecules (electrophiles, nucleophiles, etc.)
as well as provide insight into non-covalent intermolecular interactions.43 For example,
Figure 4A shows the structure of mesterolone (analyte 1) which has one hydroxyl group
extending from the carbon ring on the left-hand side while Figure 4B illustrates
oxandrolone (analyte 2), which has an ester in the same region. The minimum electrostatic
potential energy increases in magnitude from analyte 1 to analyte 2, suggesting that analyte
2 has greater reactivity towards other species. In analyte 2, this change in structure also
results in an increased polar surface area, defined as the area on the surface of a molecule
that is affected by the charge of electronegative atoms and elements such as nitrogen and
oxygen atoms as well as any hydrogens that are bonded to these elements.44–46 There is
also a much higher dipole moment, the magnitude of the sum of net charge in a molecule
based on the combination of nuclear and electron charges, which provides substantial
insight into chemical reactivities of the species.47,48 The increase in these characteristics
from analyte 1 to analyte 2 in turn decreases the interaction of analyte 2 with the nonpolar
binding pocket of the cyclodextrin hosts while the interactions between analyte 1 and the
nonpolar binding pocket increase. Analytes 3 and 4 have similarly high polar surface areas
relative to analyte 2, which explains why the analyte-induced modulation caused by analyte
1 is noticeably higher than those of the other analytes.
In contrast to analytes 2-4 which show markedly higher dipole moments and polar surface
areas that explain their decrease modulation values relative to analyte 1, analyte 5 has
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computed molecular properties that are remarkably similar to those of analyte 1.
Nonetheless, the differences in how analytes 1 and 5 induce fluorescence modulation are
substantial, with analyte 1 leading to markedly higher degrees of fluorescence modulation
(vide supra). Such differences may be explained not by the Spartan computed structural
information, but by the literature-reported photophysical activity of analyte 5,39–42 which
can lead to interference with the analyte-induced fluorescence modulation and complicate
the observed results. NMR was used to investigate the interaction profiles of the analytes
with β-CD. The only interaction seen was between the analytes and the out rim of the
cyclodextrin and was indicated by a very slight shift in the two hydroxyl peaks located
downfield of the aliphatic groups. There was not a large enough shift in spectra to confirm
covalent bonding, only illustrating the analytes do you not readily enter the cavity of the
cyclodextrin. Full NMR spectra can be seen in the ESI of this manuscript.
Array Generation Experiments
The ability of the analyte-induced fluorescence modulation to provide unique, highly
selective signals for each analyte was determined through the use of linear discriminant
analysis (LDA). By using the various cyclodextrin hosts as predictors for the system, we
determined that each analyte generates an extremely well-separated signal in the LDA
plots, regardless of whether 5 µL, 10 µL, or 20 µL, a range from 6 µM to just under 30
µM, of the analyte solution was used (Figure 5). The final concentrations of these analytes
in the fluorescence modulation trials can be found in the ESI of this manuscript. Of note,
these plots include tetrahydrofuran (THF) as a control analyte, because that was the solvent
used in the steroid solutions, and the well-separated signal of the THF indicates that the
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analytes all induce fluorescence responses that are unique from the response generated by
their solvent alone.

Figure 45. Arrays generated using the three cyclodextrin hosts as the predictors for the (A)
5 µL addition trials, (B) 10 µL addition trials and (C) 20 µL addition trials.
In addition to the well-separated signals between each analyte (apparent via visual
inspection of Figure 5), introduction of analytes as unknowns into the system after
classification resulted in 100% accurate classification of the analytes (see ESI for more
details). Interestingly, as the additions increased in volume, the average cumulative
proportion of total dispersion, a measure of the separation between signals, also increased.
The 20 µL trials had an average of 96.7% dispersion while the 5 µL and 10 µL trials had
an average dispersion of 86.4% and 96.2% dispersion, respectively. This increase in
dispersion is easily understandable, as higher concentrations of analytes lead to increased
interactions with the fluorophore-cyclodextrin system and concomitant greater separation
between signals.
Due to the differences in the observed cumulative proportions of total dispersion, we
decided to further investigate system responsiveness to the analytes at the variety of
concentrations investigated. Linear discriminant analysis of the signals generated from all
analytes at all concentrations are summarized in Figure 6A (with a THF control signal) and
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Figure 6B (without the THF control signal included). Of note, although well-separated
signals were generated for all analytes, the signal for THF in Figure 6A has some overlap
with the analytes investigated. When the THF signal was eliminated from the analysis,
100% separation was observed. Moreover, the closely grouped but still well-separated
points on the plots represent the same analyte at different concentrations, which strongly
suggests that quantitative analyte determination can also occur.

Figure 46. Arrays of fluorescence modulation data with three different addition volumes
generated using the cyclodextrin hosts as predictors for all analytes (A) including THF as
a control analyte; and (B) excluding THF as a control analyte
Limit Detection and Quantification Experiments
In addition to determining the ability of the system to selectively distinguish between
different analytes, the ability of the system to sensitively select analytes at low
concentrations is critically important in practical detection devices. To that end, the limits
of detection and limits of quantification were calculated for all analytes in each of the
cyclodextrin solutions, following literature reported procedures (see ESI for more details),
and key data is summarized in Table 4.
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Table 37. Limits of detection (µM) calculated for analytes 1-5 in the cyclodextrin host
systemsa
Analyte
1
2
3
4
5

β-CD
17.03
11.39
8.914
7.665
6.108

Me-β-CD
5.300
3.886
0.148
5.981
0.049

2-HP-β-CD
2.335
3.352
1.886
0.775
3.587

a

Values calculated using procedure found in the ESI of this manuscript. All results represent an average of
at least four trials.

Overall, the limits of detection using unmodified β-cyclodextrin were higher than the limits
of detection obtained using the other supramolecular hosts, and reflects both the lower
modulation values as well as the presumed weaker interactions between β-cyclodextrin and
the steroid analytes. Of note, all limits of detection reported in Table 4 are markedly lower
than the known concentrations of steroids found in urine testing following illegal doping
activities, 49,50 which highlights the potential of this system to be used in practical detection
applications.
CONCLUSION
As illegal doping scandals become more prevalent in practice for athletes in high level
competition, the need for a rapid on-site detection system grows. The fluorescence
modulation system introduced herein shows significant promise as a tool for the detection
of illegal steroids. This system, which relies on cyclodextrin-promoted interactions
between the target analytes and a high-quantum yield fluorophore, enabled 100% selective
differentiation between response patterns of the structurally similar anabolic steroids as
well as different concentrations of the analytes, as well as limits of detection that were
lower than concentrations reported in illegal doping scenarios. Future research in this area
will focus on incorporating more analytes as well as transitioning these promising results
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to a solid-state detection system. Work towards these goals is currently underway in our
laboratory, and the results of these and other investigations will be reported in due course.
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MATERIALS AND METHODS
The anabolic steroid analytes, chemicals required to make buffer solutions, fluorophore
Rhodamine 6G, and solvent tetrahydrofuran were obtained from Sigma-Aldrich Chemical
company and the cyclodextrins were obtained from Tokyo Chemical Industry (TCI). All
chemicals were used as received without further purification. All fluorescence
measurements were performed using a Shimadzu RF 6000 spectrophotometer. The
excitation and emission slit widths were set to 3.0 nm. All fluorescence spectra were
integrated vs. wavenumber on the X-axis using OriginPro 2019 Version 9.60. All arrays
were generated using SYSTAT Version 13.1. All NMR spectra were taken using a
Bruker 400 MHz NMR and analyzed with MestReNova 14.1 software.
DETAILS OF ANALYTES AND FLUOROPHORES

Figure 47: Structure of anabolic analytes (compound 1: Mesterolone; compound 2:
Oxandrolone; compound 3: Oxymetholone; compound 4: Stanozolol; compound 5:
Trenbolone) and fluorophore Rhodamine 6G (compound 6)
All analyte samples were prepared at a concentration of 1.0 mg/mL in THF. The
fluorophore solution was prepared at a concentration of 0.1 mg/mL in THF. An 0.1 M
citrate buffer was prepared by combining 2.409 grams of sodium citrate and 0.347 grams
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of citric acid in a 1.0 L volumetric flask and diluting to the mark with distilled water. The
pH of the buffer was measured at 6.1, and remained consistent throughout the
experimental procedures. Cyclodextrin solutions were prepared at a concentration of 10
mmol in the citrate buffer. The final concentrations of the analytes and fluorophore are
shown in Table S1, below:
Table 38: Concentration of analytes and fluorophore in
solution prior to dilution via sample preparation
Compound Number

Concentration (mM)

1

3.28

2

3.26

3

3.01

4

3.04

5

3.62

6

2.09

EXPERIMENTAL PROCEDURES
Experimental Procedure for Fluorescence Modulation Experiments
Fluorescence modulation experiments were done with 5 µL, 10 µL, and 20 µL sequential
additions of analyte. The fluorescence modulation values for each analyte-cyclodextrin
combination was determined in the following procedure:
1. 100 µL of fluorophore 6 solution (0.1 mg/mL) in THF was measured into six 15
mL glass vials (vial 1 for THF, vial 2 for analyte 1, vial 3 for analyte 2, etc.). 2.00
mL of a 10 mM cyclodextrin in citrate buffer and 0.40 mL 0.1 M citrate buffer were
added to each (citrate buffer was at pH 6.1). The vials were capped and left to
stabilize for 48 hours in a dark drawer.
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2. After the 48 hours, the contents of one vial and 5.0 µL of analyte were added to the
cuvette and stirred thoroughly to ensure homogeneity. The solution was excited at
490 nm and recorded from 500-800 nm. Four repeat measurements were taken. This
step was repeated for each analyte and an additional time, adding 5.0 µL of THF
instead of an analyte solution to use as a control.
3. Step 1 and 2 were repeated for each analyte-cyclodextrin combination (18 trials in
total). In all cases, the solution was excited at the same wavelength (490 nm) and
the emission spectra from 500 to 800 nm was recorded four times.
4. To conduct an experiment with no cyclodextrin present, step 1 was repeated but
citrate buffer solution was substituted in place of the cyclodextrin solution. The
contents of the vials were then 100 µL of fluorophore 6 solution and 2.4 mL of 0.1
M citrate buffer.
5. After 48 hours, step 2 was repeated using this set of solutions containing no
cyclodextrin for each analyte. The solutions were excited at the same wavelength
(490 nm) and the emission spectra from 500 to 800 nm was recorded four times.
6. Emission spectra were integrated versus wavenumber on the X-axis using
OriginPro software and fluorescence modulation ratios were determined according
to Equation 1, below:
Fluorophore Modulation Ratios = Flanalyte / Flblank

(Eq.1)

where Flanalyte represents the integrated fluorescence emission of the fluorophore in
the presence of the analyte and Flblank represents the integrated fluorescence
emission of the fluorophore in the absence of the analyte.
7. These ratios were recorded and are show in Table S4.
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Step 2 and 5 were repeated with sequential additions for total addition amounts of 10 µL
and 20 µL of analyte. The final concentrations of the analytes and the fluorophore in
solution using each of the three addition protocols are summarized in Table S2, below:
Table 39: Final concentrations (µM) of analytes and fluorophore
in fluorescence modulation trials
Compound
1
2
3
4
5
6

5 µL
6.419
6.419
5.890
5.949
7.226
8.334

10 µL
12.81
12.81
11.76
11.88
14.42
8.317

20 µL
25.53
25.53
23.42
23.67
28.73
8.284

Experimental Procedure for Limit of Detection Experiments
The limit of detection (LOD), defined as the lowest concentration of the analyte that can
be detected, was obtained using the calibration curve method, following procedures
reported by Loock et. al.1 The limit of quantification (LOQ) is the lowest concentration of
analyte that can be reliably and accurately quantified. The limit of detection and
quantification experiments were conducted following literature-reported procedures.1,2
LOD experiments were done with sequential 5 µL additions of analyte, according to the
procedures listed below:
1. 100 µL of fluorophore 6 solution (0.1 mg/mL) in THF was measured into a 15 mL
glass vial. 2.00 mL of a 10 mM cyclodextrin in citrate buffer and 0.40 mL 0.1 M
citrate buffer were added (citrate buffer was at pH 6). The vial was capped and left
to stabilize for 48 hours.
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2. The solution was transferred to a quartz cuvette and then excited at 490 nm and the
fluorescence emission spectra was recorded from 500 to 800 nm. Each fluorescence
measurement was repeated six times
3. 5.0 µL of the analyte solution in THF was added to the cuvette and stirred
thoroughly to ensure homogeneity. The solution was excited at the same
wavelength (490 nm) and the emission was measured between 500 nm and 800 nm.
Six repeat measurements were taken.
4. Step 2 was repeated four times for total addition volumes of 10 µL, 15 µL, 20 µL,
and 25 µL of the analyte solution. In all cases, the solution was excited at the same
wavelength (490 nm) and the emission spectra from 500 to 800 nm was recorded
six times.
5. Emission spectra were integrated versus wavenumber on the X-axis using
OriginPro software, and were used to generate calibration curves with analyte
concentration on the X-axis and integrated fluorescence emission on the Y-axis.
The curve was fitted with a linear trendline and the equation of the line was
determined.
6. The measurements from Step 1, the emission spectra of the combination of the
Rhodamine solution and β-cyclodextrin solution with no addition of analyte, are
referred to as the blank in the following calculations.
7. The limit of the blank (LODblank) is defined according to the following equation:
LODblank = mblank – 3(SDblank)

(Eq. 2)

where mblank is the mean of the blank integrations and SDblank is the standard
deviation of those measurements.
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8. The LODblank was then entered into the equation determined in Step 4 as the y-value.
The corresponding x-value was calculated. This value is the LOD of the analyte in
µM in the system.
9. The LOQ (LOQblank) was calculated in a similar manner to the LOD. The limit of
quantification of the blank is defined according to the following equation:
LOQblank = mblank – 10(SDblank).

(Eq. 3)

10. This value is then entered as the y-value from step 4 and the corresponding x-value
was calculated. This is the value of the LOQ of the analyte for the system in µM.
All steps were repeated for each analyte-cyclodextrin combination:
(5 analytes x 3 cyclodextrin solutions = 15 trials).
The summary tables of these results for each analyte-cyclodextrin combination are shown
in Tables S4-S6 (vide infra).
Experimental Procedure for Array Generation Experiments
Linear discriminant analysis was performed using SYSTAT 13 statistical computing
software with the following software settings3:
(a) Classical Discriminant Analysis
(b) Grouping Variable: Analytes
(c) Predictors: Cyclodextrin hosts
(d) Long-Range Statistics: Mahal.
These experiments were then repeated using only two predictors (i.e. cyclodextrins) instead
of all three, and the results of array-based analysis for each pair of predictors is reported
herein as well.
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Experimental Procedure for Computational Experiments
Spartan version ’18 was used to calculate the equilibrium molecular conformations of each
analyte in their ground states in the gas phase using a semi-empirical PM3 model for each
analyte. This allowed an electrostatic potential map surface to be overlaid over the
molecules with the mesh overlay function.
Experimental Procedure for 1H NMR Titration Experiments
All analytes and β-cyclodextrin solutions were prepared at a concentration of 10 mM in
deuterated dimethyl sulfoxide (DMSO). 1H NMR samples with total volumes of 0.50 mL
were prepared in Wilmad precision NMR tubes according to the details listed below:
Sample 1: β-CD only
Sample 2: Analyte only
Sample 3: A molar ratio of 1:2 of analyte to β-CD
Sample 4: A molar ratio of 1:1 of analyte to β-CD
Sample 5: A molar ratio of 2:1 of analyte to β-CD.
These samples were unheated and were at room temperature when spectra were taken. A
1

H NMR spectrum was taken of each using a Bruker 400 MHz NMR. These NMR spectra

were analyzed using MestReNova 14.1 software.
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SUMMARY TABLES
Summary Tables for Fluorescence Modulation Experiments
Table 40. Fluorescence modulation results obtained for analytes 1-5 with various
cyclodextrins in the presence of fluorophore 6a
Addition
Analyte
amount
5 μL

10 μL

20 μL

β-CD

Me-β-CD

2-HPCD

No CD

1

0.958 ± 0.001

0.956 ± 0.000

0.905 ± 0.000

1.001 ± 0.001

2

0.997 ± 0.001

0.971 ± 0.000

0.957 ± 0.000

0.973 ± 0.001

3

1.004 ± 0.001

0.956 ± 0.000

0.966 ± 0.000

1.006 ± 0.001

4

0.989 ± 0.003

0.998 ± 0.001

0.906 ± 0.000

0.979 ± 0.001

5

0.997 ± 0.001

0.978 ± 0.001

0.999 ± 0.001

1.047 ± 0.001

1

0.950 ± 0.000

0.938 ± 0.000

0.900 ± 0.000

1.004 ± 0.001

2

0.990 ± 0.001

0.967 ± 0.000

0.953 ± 0.000

0.990 ± 0.000

3

0.988 ± 0.001

0.955 ± 0.000

0.962 ± 0.000

1.009 ± 0.001

4

0.985 ± 0.002

0.995 ± 0.000

0.901 ± 0.000

0.969 ± 0.002

5

0.992 ± 0.001

0.975 ± 0.001

0.992 ± 0.000

1.040 ± 0.000

1

0.948 ± 0.001

0.932 ± 0.000

0.892 ± 0.000

0.994 ± 0.001

2

0.974 ± 0.001

0.966 ± 0.001

0.947 ± 0.000

0.987 ± 0.000

3

0.978 ± 0.001

0.954 ± 0.000

0.955 ± 0.000

1.004 ± 0.003

4

0.975 ± 0.000

0.986 ± 0.001

0.952 ± 0.000

0.972 ± 0.001

5
0.975 ± 0.001 0.969 ± 0.001 0.988 ± 0.001 1.036 ± 0.001
All values were calculated using Equation S1, and results reported represent an average
of at least four trials.
a
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Summary Tables for Limit of Detection Experiments
Table 41. Summary table for limits of detection experiments with β-CDa,b

a
a

Analyte

LOD (μM)

LOQ (μM)

Equation

R²

1

17.03

46.58

y = -1292.6693x + 2133565.2492

0.8369

2

11.39

35.32

y = -2079.0320x + 2229038.8629

0.9589

3

8.914

21.42

y = -2559.6708x + 2233461.8386

0.9308

4

7.665

30.49

y = -2237.8468x + 2220576.1935

0.9776

5

6.108

24.35

y = -2308.8616x + 2241047.0782

0.9498

All LOD values were calculated using Equation 2.
All LOQ values were calculated using Equation 3.

Table 42. Summary table for limits of detection experiments with Me-β-CDa,b

a
a

Analyte

LOD (μM)

LOQ (μM)

Equation

R²

1

5.300

11.72

y = -27374.1167x + 31229827.0035

0.8451

2

3.886

18.34

y = -11127.1906x + 31855034.7259

0.9193

3

0.148

4.102

y = -9482.3445x + 31383949.2786

0.8929

4

5.981

18.21

y = -16056.2718x + 32744010.5956

0.9379

5

0.049

4.586

y = -21626.3876x + 32220132.7800

0.9755

All LOD values were calculated using Equation 2.
All LOQ values were calculated using Equation 3.

Table 43. Summary table for limits of detection experiments with 2-HPCDa,b

a
a

Analyte

LOD (μM)

LOQ (μM)

Equation

R²

1

2.335

7.129

y = -18245.1311x + 26534054.7777

0.9956

2

3.352

14.66

y = -12790.4792x + 28037979.4349

0.9657

3

1.886

8.361

y = -21071.8113x + 28366093.4431

0.9945

4

0.775

3.371

y = -10283.4719x + 26474157.9172

0.8972

5

3.587

11.53

y = -11788.1436x + 29202530.0773

0.9438

All LOD values were calculated using Equation 2.
All LOQ values were calculated using Equation 3.
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Summary Tables for Array Generation Experiments
With 5 µL analyte additions
Table 44. Linear discriminant analysis results with β-CD, Me-β-CD, and 2-HPCD as
predictors

Table 45. Linear discriminant analysis results using β-CD and Me-β-CD as predictors

Table 46. Linear discriminant analysis results using β-CD and 2-HPCD as predictors
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Table 47. Linear discriminant analysis results using Me-β-CD and 2-HPCD as predictors

With 10 µL analyte additions
Table 48. Linear discriminant analysis results with β-CD, Me-β-CD, and 2-HPCD as
predictors

Table 49. Linear discriminant analysis results using β-CD and Me-β-CD as predictors
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Table 50. Linear discriminant analysis results using β-CD and 2-HPCD as predictors

Table 51. Linear discriminant analysis results using Me-β-CD and 2-HPCD as predictors

With 20 µL analyte additions
Table 52. Linear discriminant analysis results using β-CD, Me-β-CD, and 2-HPCD as
predictors
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Table 53. Linear discriminant analysis results using β-CD and Me-β-CD as predictors

Table 54. Linear discriminant analysis results using β-CD and 2-HPCD as predictors

Table 55. Linear discriminant analysis results using Me-β-CD and 2-HPCD as predictors
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All Additions with THF
Table 56. Linear discriminant analysis results with β-CD, Me-β-CD, and 2-HPCD as
predictors

All Additions excluding THF
Table 57. Linear discriminant analysis results with β-CD, Me-β-CD, and 2-HPCD as
predictors
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SUMMARY FIGURES
Summary Figures for Individual Fluorescence Modulation Experiments using
fluorophore 6
With 5 µL analyte addition
β-CD

Figure 48. Fluorescence modulation of analyte 1 in the presence of β-CD

Figure 49. Fluorescence modulation of analyte 2 in the presence of β-CD

Figure 50. Fluorescence modulation of analyte 3 in the presence of β-CD
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Figure 51. Fluorescence modulation of analyte 4 in the presence of β-CD

Figure 52. Fluorescence modulation of analyte 5 in the presence of β-CD
Me-β-CD

Figure 52. Fluorescence modulation of analyte 1 in the presence of Me-β-CD
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Figure 53. Fluorescence modulation of analyte 2 in the presence of Me-β-CD

Figure 54. Fluorescence modulation of analyte 3 in the presence of Me-β-CD

Figure 55. Fluorescence modulation of analyte 4 in the presence of Me-β-CD
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Figure 56. Fluorescence modulation of analyte 5 in the presence of Me-β-CD
2-HPCD

Figure 57. Fluorescence modulation of analyte 1 in the presence of 2-HPCD

Figure 58. Fluorescence modulation of analyte 2 in the presence of 2-HPCD
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Figure 59. Fluorescence modulation of analyte 3 in the presence of 2-HPCD

Figure 60. Fluorescence modulation of analyte 4 in the presence of 2-HPCD

Figure 61. Fluorescence modulation of analyte 5 in the presence of 2-HPCD
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No CD

Figure 62. Fluorescence modulation of analyte 1 in the presence of no CD

Figure 63. Fluorescence modulation of analyte 2 in the presence of no CD
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Figure 64. Fluorescence modulation of analyte 3 in the presence of no CD

Figure 65. Fluorescence modulation of analyte 4 in the presence of no CD

Figure 66. Fluorescence modulation of analyte 5 in the presence of no CD
With 10 µL analyte addition
β-CD
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Figure 67. Fluorescence modulation of analyte 1 in the presence of β-CD

Figure 68. Fluorescence modulation of analyte 2 in the presence of β-CD

Figure 69. Fluorescence modulation of analyte 3 in the presence of β-CD

Figure 70. Fluorescence modulation of analyte 4 in the presence of β-CD
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Figure 71. Fluorescence modulation of analyte 5 in the presence of β-CD
Me-β-CD

Figure 72. Fluorescence modulation of analyte 1 in the presence of Me-β-CD

Figure 73. Fluorescence modulation of analyte 2 in the presence of Me-β-CD
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Figure 74. Fluorescence modulation of analyte 3 in the presence of Me-β-CD

Figure 75. Fluorescence modulation of analyte 4 in the presence of Me-β-CD

Figure 76. Fluorescence modulation of analyte 5 in the presence of Me-β-CD
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2-HPCD

Figure 77. Fluorescence modulation of analyte 1 in the presence of 2-HPCD

Figure 78. Fluorescence modulation of analyte 2 in the presence of 2-HPCD

Figure 79. Fluorescence modulation of analyte 3 in the presence of 2-HPCD
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Figure 80. Fluorescence modulation of analyte 4 in the presence of 2-HPCD

Figure 81. Fluorescence modulation of analyte 5 in the presence of 2-HPCD
No CD

Figure 82. Fluorescence modulation of analyte 1 in the presence of no CD
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Figure 83. Fluorescence modulation of analyte 2 in the presence of no CD

Figure 84. Fluorescence modulation of analyte 3 in the presence of no CD

Figure 85. Fluorescence modulation of analyte 4 in the presence of no CD
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Figure 86. Fluorescence modulation of analyte 5 in the presence of no CD
With 20 µL analyte addition
β-CD

Figure 87. Fluorescence modulation of analyte 1 in the presence of β-CD

Figure 88. Fluorescence modulation of analyte 2 in the presence of β-CD
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Figure 89. Fluorescence modulation of analyte 3 in the presence of β-CD

Figure 90. Fluorescence modulation of analyte 4 in the presence of β-CD

Figure 91. Fluorescence modulation of analyte 5 in the presence of β-CD
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Me-β-CD

Figure 92. Fluorescence modulation of analyte 1 in the presence of Me-β-CD

Figure 93. Fluorescence modulation of analyte 2 in the presence of Me-β-CD

Figure 94. Fluorescence modulation of analyte 3 in the presence of Me-β-CD
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Figure 95. Fluorescence modulation of analyte 4 in the presence of Me-β-CD

Figure 96. Fluorescence modulation of analyte 5 in the presence of Me-β-CD
2-HPCD

Figure 97. Fluorescence modulation of analyte 1 in the presence of 2-HPCD
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Figure 98. Fluorescence modulation of analyte 2 in the presence of 2-HPCD

Figure 99. Fluorescence modulation of analyte 3 in the presence of 2-HPCD

Figure 100. Fluorescence modulation of analyte 4 in the presence of 2-HPCD
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Figure 101. Fluorescence modulation of analyte 5 in the presence of 2-HPCD
No CD

Figure 102. Fluorescence modulation of analyte 1 in the presence of no CD

Figure 103. Fluorescence modulation of analyte 2 in the presence of no CD
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Figure 104. Fluorescence modulation of analyte 3 in the presence of no CD

Figure 105. Fluorescence modulation of analyte 4 in the presence of no CD

Figure 106. Fluorescence modulation of analyte 5 in the presence of no CD
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Summary Figures for Combined Fluorescence Modulation Experiments using
Fluorophore 6

A

B

C

Figure 107. Fluorescence modulation of fluorophore 6 induced by: (A) 5 µL of THF (B)
10 µL of THF (C) 20 µL of THF in the presence of all hosts

A

B

C

Figure 108. Fluorescence modulation of fluorophore 6 induced by: (A) 5 µL of analyte 1
(B) 10 µL of analyte 1 (C) 20 µL of analyte 1 in the presence of all hosts

A

B

C

Figure 109. Fluorescence modulation of fluorophore 6 induced by: (A) 5 µL of analyte 2
(B) 10 µL of analyte 2 (C) 20 µL of analyte 2 in the presence of all hosts
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A

B

C

Figure 110. Fluorescence modulation of fluorophore 6 induced by: (A) 5 µL of analyte 3
(B) 10 µL of analyte 3 (C) 20 µL of analyte 3 in the presence of all hosts

A

B

C

Figure 111. Fluorescence modulation of fluorophore 6 induced by: (A) 5 µL of analyte 4
(B) 10 µL of analyte 4 (C) 20 µL of analyte 4 in the presence of all hosts

A

B

C

Figure 112. Fluorescence modulation of fluorophore 6 induced by: (A) 5 µL of analyte 5
(B) 10 µL of analyte 5 (C) 20 µL of analyte 5 in the presence of all hosts
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Summary Figures for Limit of Detection (LOD) Experiments
Experiments were carried out with 5 µL sequential additions of analytes with fluorophore
6 in the presence of all cyclodextrin hosts.
LOD calibration curves of analytes in presence of β-CD and fluorophore 6

Figure 113. LOD calibration curve of analyte 1

Figure 114. LOD calibration curve of analyte 2

Figure 115. LOD calibration curve of analyte 3
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Figure 116. LOD calibration curve of analyte 4

Figure 117. LOD calibration curve of analyte 5
LOD calibration curves of analytes in presence of Me-β-CD and fluorophore 6

Figure 118. LOD calibration curve of analyte 1
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Figure 119. LOD calibration curve of analyte 2

Figure 120. LOD calibration curve of analyte 3

Figure 121. LOD calibration curve of analyte 4
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Figure 122. LOD calibration curve of analyte 5
LOD calibration curves of analytes in presence of 2-HPCD and fluorophore 6

Figure 123. LOD calibration curve of analyte 1

Figure 124. LOD calibration curve of analyte 2
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Figure 125. LOD calibration curve of analyte 3

Figure 126. LOD calibration curve of analyte 4

Figure 127. LOD calibration curve of analyte 5
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Summary Figures for Array Generation Experiments
With 5 µL analyte additions

Figure 128. Linear discriminant analysis results with β-CD, Me-β-CD, and 2-HPCD as
predictors

Figure 129. Linear discriminant analysis results using β-CD and Me-β-CD as predictors

Figure 130. Linear discriminant analysis results using β-CD and 2-HPCD as predictors
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Figure 131. Linear discriminant analysis results using Me-β-CD and 2-HPCD as predictors
With 10 µL analyte additions

Figure 132. Linear discriminant analysis results with β-CD, Me-β-CD, and 2-HPCD as
predictors

Figure 133. Linear discriminant analysis results using β-CD and Me-β-CD as predictors

113

Figure 134. Linear discriminant analysis results using β-CD and 2-HPCD as predictors

Figure 135. Linear discriminant analysis results using Me-β-CD and 2-HPCD as predictors
With 20 µL analyte additions

Figure 136. Linear discriminant analysis results with β-CD, Me-β-CD, and 2-HPCD as
predictors
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Figure 137. Linear discriminant analysis results using β-CD and Me-β-CD as predictors

Figure 138. Linear discriminant analysis results using β-CD and 2-HPCD as predictors

Figure 139. Linear discriminant analysis results using Me-β-CD and 2-HPCD as predictors
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All Additions with THF

Figure 140. Linear discriminant analysis results with β-CD, Me-β-CD, and 2-HPCD as
predictors
All Additions excluding THF

Figure 141. Linear discriminant analysis results with β-CD, Me-β-CD, and 2-HPCD as
predictors
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Summary Figures for Computational Experiments
Spartan ’18 Electrostatic Potential Map Diagrams

Figure 142. Electrostatic potential map of analyte 1 in the gas phase at its most stable (i.e.
“ground state” configuration)

Figure 143. Electrostatic potential map of analyte 2 in the gas phase at its most stable (i.e.
“ground state” configuration)
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Figure 144. Electrostatic potential map of analyte 3 in the gas phase at its most stable (i.e.
“ground state” configuration)

Figure 145. Electrostatic potential map of analyte 4 in the gas phase at its most stable (i.e.
“ground state” configuration)
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Figure 146. Electrostatic potential map of analyte 5 in the gas phase at its most stable (i.e.
“ground state” configuration)
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Summary Figures for NMR Experiments
Stacked NMR spectra (Full spectra from 0 ppm to 6 ppm)

Figure 147. Stacked NMRs of (A) 2:1 analyte 1:β-cyclodextrin (B) 1:1 analyte 1:βcyclodextrin (C) 1:2 analyte 1:β-cyclodextrin (D) analyte 1 and (E) β-cyclodextrin
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Figure 148. Stacked NMRs of (A) 2:1 analyte 2:β-cyclodextrin (B) 1:1 analyte 2:βcyclodextrin (C) 1:2 analyte 2:β-cyclodextrin (D) analyte 2 and (E) β-cyclodextrin
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Figure 149. Stacked NMRs of (A) 2:1 analyte 3:β-cyclodextrin (B) 1:1 analyte 3:βcyclodextrin (C) 1:2 analyte 3:β-cyclodextrin (D) analyte 3 and (E) β-cyclodextrin
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Figure 150. Stacked NMRs of (A) 2:1 analyte 4:β-cyclodextrin (B) 1:1 analyte 4:βcyclodextrin (C) 1:2 analyte 4:β-cyclodextrin (D) analyte 4 and (E) β-cyclodextrin
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Figure 151. Stacked NMRs of (A) 2:1 analyte 5:β-cyclodextrin (B) 1:1 analyte 5:βcyclodextrin (C) 1:2 analyte 5:β-cyclodextrin (D) analyte 5 and (E) β-cyclodextrin
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Stacked NMR spectra (Zoomed-in spectra from 5.63 ppm to 5.77 ppm)

Figure 152. Stacked NMRs of (A) 2:1 analyte 1:β-cyclodextrin (B) 1:1 analyte 1:βcyclodextrin (C) 1:2 analyte 1:β-cyclodextrin (D) analyte 1 and (E) β-cyclodextrin
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Figure 153. Stacked NMRs of (A) 2:1 analyte 2:β-cyclodextrin (B) 1:1 analyte 2:βcyclodextrin (C) 1:2 analyte 2:β-cyclodextrin (D) analyte 2 and (E) β-cyclodextrin
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Figure 154. Stacked NMRs of (A) 2:1 analyte 3:β-cyclodextrin (B) 1:1 analyte 3:βcyclodextrin (C) 1:2 analyte 3:β-cyclodextrin (D) analyte 3 and (E) β-cyclodextrin
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Figure 155. Stacked NMRs of (A) 2:1 analyte 4:β-cyclodextrin (B) 1:1 analyte 4:βcyclodextrin (C) 1:2 analyte 4:β-cyclodextrin (D) analyte 4 and (E) β-cyclodextrin
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Figure 156. Stacked NMRs of (A) 2:1 analyte 5:β-cyclodextrin (B) 1:1 analyte 5:βcyclodextrin (C) 1:2 analyte 5:β-cyclodextrin (D) analyte 5 and (E) β-cyclodextrin
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